Davies, Ross

Overview 

Dr. Ross Davies is a Cardiologist in the Division of Cardiology at the University of Ottawa Heart Institute and Professor in the Faculty of Medicine at the University of Ottawa.

Background 

Dr. Davies received his BSc (Hons) in Genetics from McGill University in Montreal in 1970 and his Medical Degree from the University of Toronto in 1974. He trained in Internal Medicine and Cardiology at the Toronto General Hospital and St. Michael’s Hospital in Toronto. In 1978, he was certified as a Fellow of the Royal College of Physicians and Surgeons of Canada (FRCPC). Supported by the Heart and Stroke Foundation of Canada, he worked as a Research Fellow at Yale-New Haven Hospital in Connecticut and was certified as a Fellow of the American College of Cardiology in 1980. In 2002, he obtained his Fellowship Certification exams from the American Society of Nuclear Cardiology.

Dr. Davies initiated the Nuclear Cardiology Program at the Heart Institute and was Director until 1998. He was an inaugural member of the Heart Transplant Team in 1984 and served as its Medical Director until 2003. He has served as President of the Medical and Scientific Staff at the Institute since 2001.

Davies was the Principal Investigator of a Health Canada grant toward development of a Canadian Cardiovascular Information Network.

Research & Clinical Interests 

Dr. Davies’ clinical interests include heart failure and transplantation, nuclear cardiology and PET imaging. His research focuses on cardiovascular databases.

Publications 

LATEST PUBLICATIONS

  • Ruddy TD, Mohammad MH, Chow BJ, Dalipaj MM, de Kempt RA, Ali I, Wells RG, Davies RA, Beanlands RS. Extent of dipyridamole induced hypoperfusion with 99mTc tetrofosmin and sestamibi SPECT imaging compared to 82Rb PET imaging. SNM (submitted).
  • Ukkonen H, Burwash IG, de Kemp RA, Dafoe W, Haddad H, Yoshinaga K, Davies RA, Da Silva JN, Beanlands RS. Ventilatory efficiency (VE/VCO2 slope) with right ventricular oxidative metabolism in patients with congestive heart failure. Eur J Heart Fail 2008 Nov;10(11)1117-1122.
  • Anselm A, Cantarovich M, Davies R, Grenon J, Haddad H. Prolonged basiliximab use as an alternative to calcineurin inhibition to allow renal recovery late after heart transplantation. J Heart Lung Transplant 2008 Sep;27(9):1043-1045.
  • Galiwango P, Schukla D, Davies RA, Chow BJW. A leaky roof. Lancet (submitted April 2008).
  • Meirovich YF, Veinot JP, de Bold ML, Haddad H, Davies RA, Masters RG, Hendry PJ, de Bold AJ. Relationship between natriuretic peptides and inflammation: proteomic evidence obtained during acute cellular cardiac allograft rejection in humans. J Heart Lung Transplant 2008 Jan;27(1):31-37.

PAPERS IN REFEREED JOURNALS

  • Davies RA, Newman DM, Phillips MJ, Laidlaw JC, Zinman B. Acquired hypertrichosis lanuginosa as a sign of internal malignancy. Canadian Medical Association Journal 118: 1090 - 1096, 1978.
  • Davies RA, Patt NL, Sole MJ. Localization of pheochromocytoma by selective venous cathetrization and assay of plasma catecholamines. Canadian Medical Association Journal 102: 539 - 353, 1979.
  • Berger HJ, Matthay RA, Davies RA, Zaret BL, and Gottschalk A. Comparison of exercise right ventricular performance in chronic obstructive pulmonary disease and coronary artery disease: Non-invasive assessment by quantitative radionuclide angiography. Invest Radiol 14: 342 - 353, 1979.
  • Davies RA, Thakur ML, Berger HJ, Wackers FJ, Gottschalk A, Zaret BL. Imaging the inflammatory response to acute myocardial infarction in man using Indium-111 labelled autologous leukocytes. Circulation 63: 826 - 832, 1981.
  • Berger HJ, Davies RA, Batsford WP, Hoffer PB, Gottschalk A, Zaret BL. Beat to beat left ventricular performance assessed from the equilibrium cardiac blood pool using a computerized nuclear probe. Circulation 63: 133 - 142, 1981.
  • Matthay RA, Berger HJ, Davies RA, Loke J, Mahler DA, Gottschalk A, Zaret BL. Right and left ventricular exercise performance in chronic obstructive pulmonary disease: Radionuclide assessment. Ann Int Med 93: 234 - 239, 1980.
  • Berger HH, Sands MJ, Davies RA, Wackers FJ, Thakur ML Alexander J, Lachman AS, Williams BS, Gottschalk A, Zaret BL. Exercise left ventricular performance in patients with chest pain, ischemic appearing exercise electrocardiograms and angiographically normal arteries. Ann Int Med 94: 186 - 191, 1981.
  • Davies RA, Laks H, Wackers FJ, Berger HJ, Williams B, Hammond GL, Geha AS, Gottschalk A, Zaret BL, Radionuclide assessment of left ventricular function in patients requiring intra-aortic balloon pump assistance. Ann Thoracic Surg 33: (2) 123 - 131, 1982.
  • Lewis SM, Riba AL, Berger HJ, Davies RA, Wackers FJ Th., Alexander J, Sands MJ, Cohen LS, Zaret BL. Radionuclide angiographic exercise left ventricular performance in chronic aortic regurgitation: relationship to resting echographic ventricular dimensions and systolic wall stress index. Amer Heart J 103: (4)498 - 504, 1982.
  • Matthay RA, Berger HJ, Davies RA, Loke J, Gottschalk A, Zaret BL, Improvement in cardiac performance by oral long acting theophylline in chronic obstructive pulmonary disease. Amer Heart J. 104:1022 - 1026, 1982.
  • Francis CK, Cleman M, Berger HJ, Davies RA, Giles RW, Black HR, Zito RA, Zaret BL, Left ventricular systolic performance during upright bicycle exercise in patients with essential hypertension. Amer J Med., 75:40 - 46, 1983.
  • Chan KL, Davies RA, Chambers RJ. Coronary thrombosis and subsequent lysis after a marathon. (Dr Chan, resident, Dr. Davies, supervisor). Amer Coll Card., 4: 1322 - 1325, 1984
  • Davies RA, Koshal A, Jindal S, Walley V, Runstedler B, Green M, Morton B, Chan K, Dafoe W, Saginur R, Beanlands DS, Keon WJ, University of Ottawa Heart Institute Transplant Program. J Heart Transplant Vol. 5, No. 1, 57-58, 1986.
  • Davies RA, Runstedler B, Koshal A, Walley V, Green M., Morton B., Jindal S, Beanlands DS, Keon WJ. Temporary diastolic non-compliance with preserved systolic function after heart transplantation. Transplantation Proceedings, Vol. 19, No. 4, 344-3447, 1987.
  • Bramwell NH, Davies RA, Koshal A, Tse GNW, Keon WJ, Walley VM. Fatal gastrointestinal hemorrhage due to cytomegalovirus duodenitis and ulceration following heart transplantation. Transplantation Proceedings, Vol. 18, No. 4, 3444 - 3447, 1987.
  • Ballinger JR, Gerson B, Gulenchyn KY, Ruddy TD, Davies RA. Technetium-99m red blood cell labeling in patients treated with doxorubicin. Clin Nucl Med; 13(3): 169 - 170, 1988.
  • Davies RA. Pulmonary hypertension and right heart failure in cardiac Transplantation. Transplantation Implantation Today, vol 5: 15, 1988.
  • Koshal A, Beanlands DS, Davies RA, Nair RC and Keon WJ. Urgent surgical reperfusion in acute evolving myocardial infarction. A randomized controlled study. Circulation, Suppl I (78) No. 3, I - 171-178, 1988.
  • McPhail NV, Ruddy TD, Calvin JE, Davies RA, Barber GG. A comparison of dipyridamolethallium imaging and exercise testing in the prediction of postoperative cardiac complications in patients requiring arterial reconstruction. J Vasc Surg. Jul;10(1):51-5, discussion 55-6; 1989.
  • Klein AL, Marquis JF, Higginson LA, Mortin BC, Williams WL, Davies RA, Beanlands DS. Intravenous dipridamole-induced myocardial ischemia during percutaneous transluminarl coronary angioplasty in humans. Am J Cardiol. Feb 15; 63(7):419-22; 1989.
  • Ascah KJ, Ruddy TD, Gulenchyn KY, Williams WL, Spencer PC, Kearns SA, Ballinger JR, Davies RA: Detection of myocardial salvage with combined antimyosin and thallium imaging. Eur J Nucl Med 16; 314-315:1990.
  • Koshal A, Davies RA, Keon WJ, Beanalnds DS, Nair R: Utility of bypass surgery in acute MI. Chest ; 97(6):1504; June 1990.
  • McPhail NV, Ruddy TD, Calvin JE, Barber GG, Cole CW, Davies RA, Gulenchyn KY: Comparison of left ventricular function and myocardial perfusion for evaluation or perioperative cardiac risk of abdominal aortic surgery. Can J Surg 33(3); 224-228:1990.
  • Walley VM, Rubens F, Keon WJ, Davies RA: Coronary artery compression at orthotopic cardiac transplantation, J Thoracic Cardiovascular Surgery, Letters to the editor, Vol 102;3:459-460; 1991.
  • Brennan FJ, Davies RA, Macdonald RG, MacKenzie BR, Mitchell LB, Mizgala HF, Swirsky SN, Symes JF, Tremblay JLG, Webb GD. Assessment of the cardiac patient for fitness to drive. Can J Cardiol Vol 8; 4:406-412; 1992.
  • Wolfsohn AL, Walley V, Davies RA, Keon CA, Mandana Khalili, Keon WJ: The University of Ottawa Heart Institute Cardiac Transplant Program: The First 100 Transplants. A Pathologic Study of the Explanted Hearts. Modern Pathology Vol. 5, No.2; 158-164, 1992.
  • Halle AA, Heroux A, DiSiascio G, Wilson R, Massin E, Johnson M, Stadius M, Wray R, Young J, Davies R, Walford G, Miller L, Gustavo R, Bourge R, Crandall C, Liao Y, Cowley M, Vetrovec G: Coronary Angioplasty in Cardiac Transplant Patient: Results of a Multicenter Study. Circulation, Vol 86, No 2; 458-462; 1992.
  • Halle AA, Wilson RF, Vetrovec GW and the Cardiac Transplant Angioplasty Study Group (Local Principle Investigator, Ottawa, Davies RA) Multicenter evaluation of PTCA in transplant recipients. J Heart Lung Transplant Vol 2 No 3 part 2:S138-S141; 1992.
  • Masters, R, Hendry P, Keon WJ, Koshal A, Davies R. Symbion TAH for cardiogenic shock. American Society of Artificial Internal Organs, Nashvill, USA; 1992.
  • Masters RG, Keon WJ, Simons JA, Vlad P, Davies RA, Struthers C: Pediatric Cardiac Transplantation. Can J Pediatrics Vol 4, No 4; 102-107; 1992.
  • Walley VM, Masters RG, Boone AL, Wolfsohn AL, Davies RA, Hendry PJ, Keon WJ: Analysis of Deaths following Cardiac Transplantation: The University of Ottawa Heart Institute Experience. J Heart Lung Transplant. 12:790-801; 1993.
  • Masters RG, Davies RA, Labow RS, Hendry PJ, Harmsen E, Waghray G, Meek E. Myocardial CA++ Uptake in Cardaic Transplantation. Can J Cardiol 9(SuppE): 136E; 1993.
  • Petsikas D, Davies RA, Masters R, Struthers C, Hendry PJ, Keon WJ. Functional Recovery after Urgent Heart Transplantation. Canadian J Cardiol 9(SuppE): 136E; 1993.
  • Masters, RG, Hendry PJ, Davies RA, Mussivant T, Struthers C, Keon WJ. Influence of priority status on outcome of cardiac transplantation. 3rd World Congress of ISCTS, Salzburg, Austria; 1993.
  • Masters RG, Davies RA, Keon WJ, Koshal A, Walley VM, DeBold AJ, Neuroendocrine Responses to Cardiac Transplantation. Can J Cardiol, 9:609-617; 1993.
  • Wolfson AL, Davies RA, Smith CD, Walley VM: Giant Cell Myocarditis-Like Appearance Post Transplant? An Atypical Manifestation of Rejection. Letter. J Heart Lung Transplant. Vol 13; 731-3; 1994.
  • Hendry, PJ, Masters RG, Davies RA, Smith S, Walley VM, Struthers C, Mussivand T, Lavallee G, Blohon R, Keon WJ. Artificial Heart and Ventricular Assist Device Program: An 8 year experience at the University of Ottawa Heart Institute. Circulatory Support 1994, Pittsburgh, USA; 1994.
  • Wolfsohn AL, Walley VM, Masters RG, Davies RA, Keon WJ: The Surgical Anastomoses after Orthotopic Cardiac Transplant: Clinical Complications and Morphological Observations. J Heart Lung Transplant Vol 13; 455-65; 1994.
  • Masters RD, Hendry PJ, Davies RA, Smith S, Walley WM, Keon WJ. Bridge to Cardiac Transplantation for Profound Cardiovascular Collapse. Can J Cardiol 10(Suppl C): 136C; 1994.
  • Ibrahim M. Masters RG, Hendry PJ, Davies RA, Smith S, Struthers C, Keon WJ. Determinants of Early Survival Following Cardiac Transplantation. Can J Cardiol 10(Suppl C): 137C; 1994.
  • Yvorchuk, K, Davies RA, Chan K-L. Measurement of Left Ventricular Ejection Fraction by Acoustic Quantification: Comparison with Radionuclide Angiography. Am J Cardiol.; 74:1052-1056; 1994.
  • Leenen FHH, Davies RA, Fourney A. Role of cardiac B-2 receptors in cardiac responses to exercise in cardiac transplant patients. Circulation: 91 (3): 685-690; 1995
  • Davies RA, Patient Oriented Workstation Design, in Proceedings of >Toward an Electronic Patient Record= ‘95 Symposium, vol.2, pp.532-38, Medical Records Institute, Orlando, Florida; March 14-19, 1995.
  • Veinot JP, Davies RA, Masters RG, Walley VM. Angiographic underestimation of coronary artery disease in a cardiac transplant donor. Can J Cardiol; 11 (11): 1039-1042; 1995.
  • Ibrahim M, Masters RG, Hendry P, Davies RA, Smith S, Struthers C, Walley VM, Keon WJ. Determinants of hospital survival after cardiac transplantation. Ann Thorac Surg; 59: 604- 608; 1995.
  • Donat ME, Smith SJ, Masters RG, Struthers C, Davies RA, Hendry PJ, Keon WJ. Preopeartive Hemodyncamics do not Predict Early or Late Outcome in Cardiac Transplantation. Can J Cardiol 11 (Suppl E): 72E;1995.
  • Beanlands RSB, deKemp RA, Culbert P, Smith S, Hendry PJ, Davies RA, Bedard P, Nahmias C, Firnau G, Bowen B, Coates G, Chirakel R, Fallen E, Ruddy TD. Myocardial Glucose Metabolism in Severe Ischemic Left Ventricular Dysfunction. Can J Cardiol 11(Suppl E): 104E; 1995.
  • Dumesnil JG, Dion D, Yvorchuk KJ, Davies RA, Chan KL. A New Simple and Accurate Method for Determining Left Ventricular Ejection Fraction by Doppler Echocardiography. Can J of Cardiol; 11 (11): 1007- 1014; 1995.
  • Mussivand T, Boyd D, Chambers J, Chow L, Davies R, Diguer M, Hendry P, Hirsh J, Ho C, Holmes K, Hum A, Irvine J, Keaney M, Kieser T, Koshal A, Labow R, Laplante R, Lavalee G, Masters R, Meuller R, Milligan L, Rajagopalan K, Rubens F, Ruddy T, Walley VM, Keon WJ. In Vivo Assessment of a Totally Implantable Intrathoracic Ventricular Assist Device. Can J Cardio 11(Suppl E): 140E; 1995.
  • Lee AP, Walley VM, Ascah KJ, Veinot JP, Davies RA, Keon WJ. A Fenestrated Aortic Valve Contributing to Iatrogenic Aortic Insufficiency Post Mitral Valve Replacement. Cardiovascular Pathology. Cardiovasc Path; 5 (2): 85; 1996
  • Lee S, Veinot JP, Smith S, Davies RA, Walley V. External cardioversion-related cardiac damage. Cardiovasc Pathol; Vol 5, No 2: 97-100; 1996
  • Halle III AA, DiSciascio G, Massin EK, Wilson RF, Johnson MR, Miller LW, Aversano TR, Wray RB, Hunt SA, Weston MW, Davies RA, Rincon G, Chauncy CC, Cowley MJ, Kubo SH, Fisher SG, Vetrovec GW. Coronary Angioplasty, Atherectomy and Bypass Surgery in Cardiac Transplant Recipients. J Am Coll Cardiol; 26[1] pp.120-128; 1995.
  • Mason JW, O=Connell JB, Herskowitz A, Billingham ME, McManus BM, Moon TE and the Myocarditis Treatment Trial Investigators. Davies RA. Efficacy of Immunosuppressive Therapy in Patients with Myocarditis. N Engl J Med; 333: 269- 275; 1995.
  • Hahn EA, Hartz VL, Moon TE, O’Connell JB, Herskowitz A., McManus B, Mason JW, and the Myocarditis Treatment Trial Investigators...Davies RA. The Myocarditis Treatment Trial: Design, Methods and Patient Enrolment. Eur Heart J; Vol 16, Suppl O: 162-167; 1995.
  • Lette J, Tatum JL, Fraser S, Miller DD, Waters DD, Heller G, Stanton EB, Seung Bom H, Leppo J, Nattel S, Davies RA-investigator for the Multicenter Dipyridamole Safety Study Investigators. Safety of dipyridamole testing in 73,806 patients: The Multicenter Dipyridamole Safety Study. J Nuc Card, vol. 2,1; 3-17, Jan/Feb 1995.
  • Johnstone DE, Abdulla Arnold A, Arnold JMO, Davies RA. Diagnosis and management of heart failure. Can J Clin Pharm, Winter 1994- not cited in 1994 PDC (reprinted from Can J Cardiol; 10(6): 613- 631; 1994.
  • Yvorchuk KJ, Davies RA, Chan KL. Measurement of left ventricular ejection fraction by acoustic quantification: comparison with radionuclide angiography. Am J Cardiol; 74(10): 1052-1056; 1994.
  • Hahn E, Hartz VL, Moon TE, O=Connell JB, Herkowitz A, McManus B and Mason J for the Myocarditis Treatment Trial Investigators (including Davies RA). The Myocarditis Treatment Trial; design, methods and patient enrolment. European Heart J (Suppl); 16:162-167; 1995..
  • Ibrahim M, Masters RG, Hendry PJ, Davies RA, Smith S, Walley VM, Struthers C, Keon WJ. Determinants of Early Survival Following Cardiac Transplantation. Ann Thorac Surg 59:604-608; 1995.
  • Davies RA, Matching Patient User and Identifiers, in the Proceedings of the >Toward an Electronic Patient Record= >96: Twelfth International Symposium on the Creation of Electronic Health Record Systems and Global Conference on Patient Cards. Medical Records Institute Symposium, San Diego; March 11-19, 1996.
  • Masters RG, Hendry PJ, Davies RA, Smith S, Struthers C, Walley VM, Mussivand T, Keon WJ. Cardiac Transplantation after Mechanical Circulatory Support: A Canadian Perspective. Ann Thorac Surg. 61(6):734-9; 1996.
  • Davies RA, Newton G, Masters RG, Saginur R, Struthers C, Walley V. Bacterial pericarditis after heart transplantation: Successful management of two cases with catheter drainage and antibiotics. Can J Cardiol. 12(7):641-644; 1996.
  • Brennan FJ, Mitchell LB, Sheldon RS, Davies RA, Macdonald RG, MacKenzie BR, Mizgala HF, Swirsky SN, Symes JF, Tremblay JLG, Webb GD. Assessment of the Cardiac Patient for Fitness to Drive: 1996 Update. Can J Cardiol. 12:1164-1170; 1996.
  • Lee AP, Walley VM, Ascah KJ, Veinot JP, Davies RA, Keon WJ. A Fenestrated Aortic Valve Contributing to Iatrogenic Aortic Insufficiency Post Mitral Valve Replacement. Cardiovascular Pathology. Cardiovasc Pathol; 5(2):85; 1996.
  • Lee S., Veinot JP, Smith S, Davies RA, Walley V. External cardioversion-related cardiac damage. Cardiovasc Pathol; 5(2): 97-100; 1996.
  • Semelhago LC, Masters RG, Hendry PJ, Davies RA, Smith S, Struthers C, Keon WJ. Influence of Recipient Age on Outcome of Cardiac Transplantation. Can J Surg 39:A9; 1996.
  • Garg R, Gorlin R, Smith T , Yusuf S and The Digitalis Investigation Group (Davies RA). The Effect of Digoxin on Mortality and Morbidity in Patients with Heart Failure. New Engl J Med; 336:525-533; 1997.
  • Stewart DJ, Cripps C, Goel R, Dahrouge S, Yau J, Tomiak E, Haun S, Soltys K, Prosser A, Davies RA. Pilot study of multiple chemotherapy resistance modulators plus epirubicin in the treatment of resistant malignancies, Cancer Chemother and Pharmacology 1997; 41:1-8.
  • Beanlands RSB, Nichol G, Visentin DE, Smith S, DeKemp RA, Hendry P, Masters R, Davies RA, Aung MT, Aubrey BA, Ruddy TA. Potential for cost savings with FDG PET imaging in patients being considered for cardiac transplantation. American Heart Association, Orlando, USA; 1997.
  • Beanlands RSB, Hendry P, Masters R, DeKemp RA, Aubrey BA, Aung MT, Ruddy TD. Delay in Revascularization is Associated with Increased Mortality in Patients with Severe LV Dysfunction and Viable Myocardium on FDG PET Imaging. American Heart Association, Orlando, USA, 1997.
  • Burns BF, Walley VM, Davies RA, Auclair F, Bormanis J. Hemophagocytic syndrome complicating cardiac transplantation. Cardiovasc Pathol; 7(1)47-50; 1998.
  • Olley PM, Davies RA, Towards a Canadian National Cardiovascular Database, Can J Cardiol; 14 (1): 21, 26 (President=s Page); 1998.
  • Carrier M, Rivard M, Latter D, Kostuk W, and the Cascade Investigators (Davies RA), Predictors of early mortality after heart transplantation: The Canadian transplant experience from 1981 to 1992, 1998 Can J Cardiol; 14(5):703- 707; 1998.
  • Hendry PJ, Masters RG, Mussivand TV, Smith S, Davies RA, Finlay S, Keon WJ. Circulatory Support for Cardiogenic Shock Due to Acute Myocardial Infarction. International Society of Heart and Lung Transplantation, Chicago, USA; 1998.
  • Hendry PJ, Masters RG, Mussivand T, Smith S, Davies RA, Keon WJ. Artificial Hearts for Cardiogenic Shock Due to Acute Myocardial Infarction. Can J Cardiol 14:187F; 1998.
  • Leenen FHH, Davies RA, Fourney A. Catecholamines and heart function in heart transplant patients: Effects of β1-versus nonselective β-blockade. Clin Parmacol Ther; 64:522-35; 1998.
  • Mussivand T, Hendry PJ, Masters RG, Bourke ME, Keaney M, Holmes KS, Ibrahim M, Ho C, Mueller, Walley WM, Davies RA, Smith S, Labow R, Keon WJ. HeartSaver VAD- A long term ventricular assist device for outpatient therapy, ASAIO J (in press).
  • Hendry PJ, Masters RG, Keaney M, Bourke M, Mussivand T, Keon WJ, Walley V and the EVAD Team (Davies RA). Evolution of an electrohydraulic ventricular assist device through in vivo testing. ASAIO J; M350- M354; 1999.
  • Masters RG, Davies RA, Veinot JP, Hendry PJ, Smith SJ, deBold AJ. Discoordinate modulation of natriuretic peptides during acute cardiac allograft rejection in humans. Circulation; 100(3):287-291; 1999.
  • Hendry PJ, Masters RG, Mussivand TV, Smith S, Davies RA, Finlay S, Keon WJ. Circulatory support for cardiogenic shock due to acute myocardial infarction: A Canadian Experience. Can J Cardiol;15(10):1090-1094; 1999.
  • Kong W, LeMay M, Labinaz M, Davies RA. Stenting of an unprotected left main coronary artery stenosis in a cardiac transplant patient. Can J Cardiol; 15(10): 1131-1135; 1999.
  • Pitt B, Poole-Wilson P, Segal R, Martinez FA, et al. Effects of Losartan Versus Captopril on Mortality in Patients with Symptomatic Heart Failure: Rationale, Design, and Baseline Characteristics of Patients in the Losartan Heart Failure Survival Study - ELITE II (Davies RA Local Principal Investigator) Journal of Cardiac Failure; 5(2): 146-154; 1999.
  • Yusuf S et al, Davies RA, local principal investigator. Effects of an Angiotensin Converting-Enzyme Inhibitor, Ramipril, on Cardiovascular Evens in High-Risk Patients. (Local Principal Investigator). The New England Journal of Medicine; 342(3):145-153; January 2000.
  • Birnie D, Green MS, Veinot JP, Tang AS, Davies RA. Interatrial conduction of atrial tachycardia in heart transplant recipients: potential pathophysiology. J Heart Lung Transplant. 19(10):1007-1010; 2000.
  • Davies, R.A. Overview of APPROACH - The Alberta Provincial Program for Outcome Assessment in Coronary Disease. Canadian Journal of Cardiology 16(10): 1222-1224; October 2000.
  • Liu et al, R A Davies, Secondary Panellist, The 2001 Canadian Cardiovascular Society Consensus Guideline Update for the Management of Heart Failure. Can J Cardiol; 17 Suppl E: 1E- 48E; 2001.
  • Veinot JP, Ascah K, Davies RA, Smith S. Coronary Artery - Posterior Interventricular Vein Fistula Post-Endomyocardial Biopsy in a Heart Transplant Patient. Canadian J Cardiol; Feb; 18(2):193-4; 2002.
  • Davies, RA, Veinot J, Smith S, Struthers C, Hendry P, Masters. Outcome of Heart Transplantation for Giant Cell Myocarditis. Journal of Heart and Lung Transplantation; Jun; 21(6):674-9; 2002.
  • Davies, RA, Veinot JP, Smith S, Struthers C, Hendry P, Masters R,. Giant Cell Myocarditis: Clinical Presentation, Bridge to Transplantation with Mechanical Circulatory Support, and Long-Term Outcome. J Heart Lung Transplant; 21(6):674-9; 2002.
  • Davies RA, Donati S, Marquis JF. Graphical Entry, Display and Report Generation of Coronary Angiography Data Using a Computerized Coronary Tree Diagram. CMBES (Canadian Medical Biological Engineering Society) Conference Proceedings, Ottawa; November 2002.
  • Ross H et al, (Davies, RA. Secondary panellist) Consensus Document on Cardiac Transplantation, presented to Canadian Cardiovascular Congress, Can J Cardiol. In press.
  • Hendry PJ, Masters RG, Davies RA, Struthers C, Mussivand TV, Keon WJ. Mechanical Circulatory Support of Pediatric Patients: The Ottawa Heart Institute Experience. Can J Cardiol; 19 (4); 409-12; March 2003.
  • Lee DS et al and the CCORT/CCS Canadian Heart Failure Quality Indicator Panel. (Davies RA, panel member) Canadian Quality Indicators for Congestive Heart Failure Care. Can J Cardiol 2003; 19(4).
  • Beanlands R, Nichol G, Ruddy TD, deKemp RA, Hendry P, Humen D, Racine N, Ross H, Benard F, Coates G, Iwanochko RM, Freeman M, Falls E, Wells G and PARR-2 Investigators. (Davies RA participant) Evaluation and Outcome and Cost-Effectiveness using and FDG PET-Guided Approach to Management of Patients with Coronary Disease and Severe LV Dysfunction (PARR-2): Rationale, Design and Methods. Controlled Clinical Trials; 24:776-794; 2003.
  • Beanlands R. Davies RA. PET and Recovery Following Revascularization (PARR-1) The Importance of Scar and the Development of a Prediction Rule for the Degree of Recovery of LV Function. J Am Col Cardiol. J Amer Coll Cardiol; 40: 1735-1743; 2003.
  • Hendry PJ, Masters RG, Davies RA, Mesana T, Struthers C, Mussivand T, Keon WJ. Mechanical Circulatory Support for Adolescent Patients: The Ottawa Heart Institute Experience. Can J Cardiol; Vol 19 No 4, March 31, 2003.
  • Healey JS, Davies RF, Smith SJ, Davies RA, Ooi DS, Prognostic Use of Cardiac Troponin T and Troponin I in Patients with Heart Failure, Can J Cardiol; 19; 383-386 2003.
  • Lee DS, Tran C, Flintoft V, Grant C, Liu PP, Tu JV, and the Canadian Cardiovascular Outcomes Research Team/Canadian Cardiovascular Society Heart Failure Quality Indicator Panel (RA Davies – Panellist), “CCORT/CCS Quality Indicators for Congestive Heart Failure Care”. Can J Cardiol; 19 (4); 2003.
  • Hendry, RH, Dipchaud, A, Giannetti N, Hirsch G, Isaac D, Singh, N, West L, White M, Ignaszewski A, Chung AM, Straatman L, Modry D, Tymchak W, Burton J, Warnica W, Azevedo JE, Kostuk W, Menkis A, Pflugfelder P, Quantz M, Davies RA, Haddad H, Masters R, Cusimano R, Delgado D, Feindel C, Rao V, Cantarovich M, Cecere R, Carrier M, Pellerin M, Doyle D, LeBlanc MH, Howlett J. “2001 Canadian Cardiovascular Society Consensus Conference on Cardiac Transplantation.” Can J. Cardiol; 19 (6): 620-54; 2003.
  • Mussivand T, Harasaki H, Litwak K, Slaughter MS, Gray LA Jr., Dowling TR, Mueller R, Masters RG, Hendry PJ, Beck-Da-Silva L, Davies R, Haddad H, Mesana TG, Keon W.J. “In vivo Evaluation of the Biocompatibility of the Totally Implantable Ventricular Assist Device (HeartSaver VAD). ASAIO J; 49 (4): 459-62; 2003.
  • Eisen HJ, Murat Tuzcu E, Dorent R, Kobashigawa j, Mancini D, Valantine-vonKaeppler HA Starling RD, Rensen KS, Hummel M, Lind JM, Abeywickrama KH, Bernhardt P. (Davies RA. Member for the RAD B253 Study Group). Everolimus for the Prevention of Allograft Rejection and Vasculopathy in Cardiac-Transplant Recipients. N Engl J Med; 349: 847-58; 2003.
  • Ross, Hendry P, Dipchand A, Giannetti N, Hirsch G, Isaac D, Singh N, West L, White M, Ignaszewski A, Chung AM, Straatman L, Modry D, Tymchak, Burton J, Warnica W, Azevedo JE, Kostuk W, Menkis A, Pflugfelder P, Quantz M, Davies RA, Haddad H, Masters R, Cusimano R, Delgado D, Feindel C, Rao V, Cantarovich M, Cecere R, Carrier M, Pellerin, Rubens FD. The influence of PMEA-coated bypass circuits on preoperative inflammatory response (commentary). Ann Thorac Surg; 75:917-918; 2003.
  • Westerman E., Aubrey B, Gauthier D, Aung M, deKemp RA, Ruddy TD, Davies RA, Beanlands RSB. Positron emission tomography: A study of PET test-related anxiety. Canadian Journal of Cardiovascular Nursing. Vol 14, No 2; 42-48; 2003.
  • Ananthasubramaniam K, Benjamin JW, Chow MD, Ruddy, TD, deKemp R, Davies RA, Beanlands, RSB, Does Electrocardiographic Q wave Burden Predict the Extent of Scar Or Hibernating Myocardium as Quantified By Positron Emission Tomography. American Journal of Cardiology; 2003.
  • Davies RA, Badovinac K, Haddad H, Hendry PJ, Masters RG, Struthers C, Veinot JP, Smith S, Mussivand TV, Mesana T, Keon WJ. Heart Transplantation at the Ottawa Heart Institute: Comparison with Canadian and International Results. Special Issue of Artificial Organs of the Canadian Artificial Organ Experience. ASAIO Journal; 28(2): 166-70; Feb. 2004.
  • Mielniczuk L, Mussivand T, Davies RA, Mesana TG, Masters RG, Hendry PJ, Keon WJ, Haddad HA. Patient Selection for Left Ventricular Assistant Devices. Special Issue of Artificial Organs of the Canadian Artificial Organ Experience. ASAIO Journal; 28(2): 152-57; Feb. 2004.
  • Haddad M, Hendry PJ, Masters RG, Mesana, T, Haddad H, Davies RA, Mussivand TV, Struthers C, Keon, WJ. Ventricular Assist Devices as a Bridge to Cardiac Transplantation: The Ottawa Experience. Accepted for publication in Special Issue of Artificial Organs of the Canadian Artificial Organ Experience. ASAIO Journal; 28(2): 136-41; Feb. 2004.
  • Haddad M, Masters RG, Hendry PJ, Mesana T, Haddad H, Davies RA, Mussivand TV, Struthers C, Keon, WJ. Improved Early Survival With the Total Artificial Heart. Special Issue of Artificial Organs of the Canadian Artificial Organ Experience. ASAIO Journal; 28(2): 161-5; Feb. 2004.
  • Davies RA, Abdullah S, Cohen, E, Knudston M, Collins-Nakai R, Lacroix C, TaylorG, TU JV, Wilson E, and Canadian Cardiovascular Information Network Investigators. Issues Influencing Development of a Canadian Cardiovascular Information Network. Can J Cardiol; 20(6):637-41; May 2004.
  • Mussivand, T., Carrier M., Chiu R.C.J., Davies RA, Delgado D., Deng M., Haddad H., Hendry P., Keon W.J., Koshal A., Masters R., Mesana T., Rao V. “Under utilization of Mechanical Circulatory Support in Canada. Why and What Can Be Done? Submitted to Can J. Cardiol.
  • Beck-da-Silva L, de Bold A, Davies RA,. Chow BJW, Ruddy TD, Fraser M, Struthers C, Haddad H. “Effects of Bisoprolol on Right Ventricular Function and Brain Natriuretic Peptide in Patients with Heart Failure. Congestive Heart Failure; 10(3):127-32; May-June 2004.
  • Seth R, deKemp RA, Ruddy TD, Kitsikis A, Hart R, Beauchesne L, Williams K, Davies RA, Labinaz M. Beanlands R. Potential utility of perfusion quantification using rubidium-82 PET in patients with three-vessel coronary artery disease measured using ribidium-82 PET. Accepted. Journal of Nuclear Cardiology 2004.
  • Beck da Silva L, deBold A, Davies RA, Fraser M, Williams K, Struthers C, Haddad H. Brain natriuretic peptide as a guideline to beta-adrenergic blocker titration in patients with heart failure. Submitted to Journal of American College of Cardiology 2004.
  • Beck da Silva L, de Bold A, Fraser M, Williams K, Struthers C, Davies RA, Haddad H. B-Type natruiretic peptide predicts successful cardioversion in patients with atrial fibrillation and maintenance of sinus rhythm. Accepted Can J. Cardiol; 2004.
  • Sylvius N, Bilinska ZT, Veinot JP, Fidzianska P, Bolongo M, Poon S, McKeown P, Davies RA, Chan KL, Tang SL, Dyack S, Jrzybowski J, Ruzyllo W, McBride H, Tesson, F. Various Degrees of Nuclear Membrane Integrity and Intranuclear Organization Impairment in Young Heart Failure Patients with Lamin A/C Mutation. Submitted to Circulation; 2004.
  • Mussivand T, Carrier C, Chiu RCJ, Davies RA, Delgado DH, Deng MC, Haddad H, Hendry PJ, Keon WJ, Koshal A, Masters RG, Mesana T, Rao V. Under-utilization of mechanical circulatory support in Canada. Why and what can be done? Artificial Organs; 28(3):278-286; March 2004.
  • Healey JS, Davies RA, Tang AS. Improvement of apparently fixed pulmonary hypertension with cardiac resynchronization therapy. J Heart Lung Transplant. May 2004; 23(5):650-2.
  • Veinot JP, Mielniczuk LM, Davies RA, Haddad H. Tricuspid valve chordal tissue in endomyocardial biopsies of patients with significant tricuspid regurgitation. Accepted. Journal of Heart and Lung Transplantation; Nov. 2004.
  • Parkash R, deKemp RA, Ruddy T, Kitsikis A, Hart R, Beauchesne L, Williams K, Davies RA, Labinaz M, Beanlands RSB. Potential utility of rubidium 82 PET quantification in patients with 3-vessel coronary disease. Journal of Nuclear Cardiology; 11(4):440-9; July-Aug. 2004.
  • White M, Haddad H, Leblanc MH, Giannetti N, Pfugfelder P, Davies RA, Isaac D, Burton J, Chan M, Azevedo E, Agnaszewski A, Busque S, Cantarovich M, Ferguson R, Genest J, Ross H. Conversion from Cyclosporine- to Tacrolimus-based Immunophophylaxis Improves Cholesterol Profile in Heart Transplant Recipients with Treated but Persistent Dyslipidemia: The Canadian Multicenter Randomized Trial of Tacrolimus vs. Cyclosporine Microemulsion. The Journal of Heart and Lung Transplantation. Vol 24, No. 7. 798-809; July 2005.
  • Ogawa T, Veinot JP, Davies RA, Haddad H, Smith SJ, Masters RG, Hendry PJ, Starling R, Kuroski de Bold, M, Ponce A, Ma KK, Williams K, de Bold, AJ. Neuroendocrine profiling of humans receiving cardiac allografts. Journal of Heart and Lung Tansplantation. Vol. 24/8. pp 1046-1054; August 2005.
  • Yoshinaga K, Chow BJW, deKemp RA, Thorn S, Ruddy TD, Davies RA, DaSilva JN, Beanlands R. Application of cardiac molecular imaging using positron emission tomography in evaluation of drug and therapeutics for cardiovascular disorders. Current Pharmaceutical Design; 11, 903-932; 2005.
  • Cunningham K, Davies RA, Catching J, Veinot JP. Pathological Quic Case: Young woman with eosinophilia and heart failure. Accepted. Archives of Pathology and Laboratory Medicine; Jan. 2005.
  • Ibrahim M, Masters R, Hynes M, Veinot JP, Davies RA. Papillary fibroelastoma of the pulmonary valve. Submitted. CHEST; 2005.
  • Ananthasubramaniam K, Chow BJ, Ruddy TD, deKemp R, Davies RA, DaSilva J, Beanlands RS. Does electrocardiographic Q wave buden predict the extent of scarring or hibernating myocardium as quantified by positron emission tomography? Can J Cardiol; Vol 21 No 1 2005.
  • Sylvius N, Bilinska ZT, Veinot JP, Fidzianska A, Bolongo PM, Poos S, McKeown P, Davies RA, Chan K-L, Tang, ASL, Dyack S, Grzybowski J, Ruzyllo W, McBride H, Tesson F. In vivo and in vitro examination of the functional significances of novel lamin gene mutations in heart failure patients. Journal of Medical Genetics. 42(8): 639-47; 2005.
  • Yoshinaga K, Chow, BJ, deKemp R, Williams K, Garrard L, Lok-tin Szeto A, Chen L, Davies RA, Ruddy T, Beanlands RS. Prognostic value of rubidium-82 perfusion positron emission tomography in patients referred after SPECT imaging. Submitted. Circulation; 2005.
  • Davies, RA, HOPE and HOPE-TOO Trial Investigators, Effects of long-term vitamin E supplementation on cardiovascular events and cancer. A randomized controlled trial. JAMA; Vol. 293, No 11. 1338-1347; March 16, 2005.
  • Haddad H, Elabbassi W, Moustafa S, Davies RA, Mesana T, Hendry P, Masters R, Mussivand T. Left ventricular assist devices as bridge to heart transplantation in congestive heart failure with pulmonary hypertension. Accepted. ASAIO; 2005.
  • Mielniczuk Lisa, Haddad H, Davies RA, Veinot JP. Tricuspid valve chordal tissue in endomyocardial biopsy specimens of patients with significant tricuspid regurgitation. The Journal of Heart and Lung Transplantation. Volume 24, Number 10; 1586-90; 2005.
  • Davies RA, HOPE/HOPE-TOO Study Investigators. Long-Term Effects of Rampiril on Cardiovascular Events and on Diabetes. Results of the HOPE Study Extension. Circulation. 1339-1346; August 2005.
  • Yoshinaga K, Chow BJ, deKemp R, Williams K, Garrard L, Lok-tin Szeto A, Chen L, Davies RA, Ruddy T, Beanlands RS. Prognostic value of rubidium-82 perfusion positron emission tomography in patients referred after SPECT imaging. Journal of American College of Cardiology; 2005.
  • Ukkonen Heikki, Burwash I, deKemp R, Haddad H, Dafoe W, Yoshinaga K, Davies RA, DaSilva Jean, Beanlands RS. Is ventilatory efficiency (VE/VCO2 slope) with exercise associated with right ventricular oxidative metabolism in patients with congestive heart failure? Submitted. Journal of American College of Cardiology; December 2005.
  • Yoshinaga K, Chow B, Williams K, Chen L, deKemp RA, Garrard L, Lok-Tin Szeto A, Davies RA, Ruddy TD, Beanlands R. Prognostic Value of Rubidium-82 Perfusion Positron Emission Tomography in Patients with Obesity. Journal of the American College of Cardiology; Volume 47, Number 4; 812-7; February 2006.
  • White M, Ross HJ, Haddad H, LeBlanc MH, Racine N, Pflugfelder P, Giannetti N, Davies RA, Azevedo E, Isaac D, Burton J, Ferguson R, Genest J. Subclinical Inflammation and Prothrombotic State in Heart Transplant Recipients: Impact of Cyclosporin Microemulsion vs. Tacrolimus. Submitted. Transplantation; 2006.
  • Yoshinaga K, Chow BJ, Williams K, Chen L, deKemp RA, Garrard L, Lok-Tin Szeto A, Aung M, Davies RA, Ruddy TD, Beanlands RS. What is prognostic value of myocardial perfusion imaging using rubidium-82 positron emission tomography. Journal of the American College of Cardiology. Volume 48, Number 5; 1029-39; September 2006.
  • Burwash I, Davies RA. Cardiac Actinomycosis: An Unusual Cause of Intracardiac Mass. Journal of the American Society of Echocardiography; Number 135; 18-25; September 2006.
  • Ukkonen H, Burwash I, de Kemp R, Dafoe W, Haddad H, Yoshinaga K, Davies RA, DaSilva J, Beanlands R. Is Ventilatory Efficiency (VE/VCO2 slope) with Exercise Associated with Right Ventricular Oxidative Metabolism in Patients with Congestive Heart Failure; Submitted 2006.
  • Peters GL, Davies RA, Veinot JP, Burwash IG. Cardiac actinomycosis: an unusual cause of an intracardiac mass. Am Soc Echocardiogr. 2006 Dec;19(12):1530.e7-11.
  • Leenan F, Coletta E, Davies RA. Prevention of Renal Dysfunction and Hypertension by Amlodipine in Heart Transplant Patients. American Journal of Cardiology; 100(3):531-5; August 2007.
  • Ibrahim M, Hendry P, Masters R, Rubens F, Lam B, Ruel M, Davies R, Haddad H, Veinot JP, Mesana T. Management of acute severe perioperative failure of cardiac allografts: A single-centre experience with a review of the literature. Can J Cardiol. 2007 Apr 23(5):363-7; May 2007 .
  • Davies RA, Beanlands, RS. F-18 Fluorodeoxyglucose Positron Emission Tomography Imaging – Assisted Management of Patients with severe Left Ventricular Dysfunction and Suspected Coronary Disease. Journal of the American College of Cardiology, In Press September 2007
  • Davies RA, Veinot JP, Williams K, Haddad H, Baker A, Donaldson J, Pugliese C, Struthers C, Masters R, Hendry P, Mesana T. Assessment of Cycolsporine Pharmacokinetic Parameters to Facilitate Conversion from CO to C2 Monitoring in Heart Transplant Recipients. Transplantation Proceedings, 2007 Dec;39(10):3334-9
  • Meirovich YF, Veinot JP, de Bold ML, Haddad H, Davies, RA, Masters RG, Hendry PJ, de Bold AJ. Relationship between natriuretic peptides and inflammation: proteomic evidence obtained during acute cellular cardiac allograft rejection in humans. J Heart Lung Transplant. 2008 Jan;27(1):31-7
  • Heikki Ukkonen, MD, PhD; Ian G Burwash, MD; Robert A de Kemp, PhD; William Dafoe, MD; Haissam Haddad, Md; Keiichiro Yoshinaga, MD; Ross A Davies, MD; Jean N Da Silva, PhD; Rob S Beanlands, MD; Ventilatory Efficiency (VE/VCO2 slope) with Right Ventricular Oxidative Metabolism in Patients with Congestive Heart Failure; Eur J Heart Fail; 2008 Nov; 10(11) 1117-22
  • Paul Galiwango, MD; Dino Schukla MD; Ross A. Davies, MD, Benjamin J.W. Chow, MD; A Leaky Roof; The Lancet; Submitted April 2008
  • Ruddy TD, Mohammad, MH, Chow BJ, Dalipaj MM, de Kempt RA, Ali I, Wells RG, Davies RA, Beanlands RS; Extent of Dipyridamole Induced Hypoperfusion with 99mTc Tetrofosmin and Sestamibi SPECT Imaging compared to 82Rb PET Imaging. SNM. Submitted.

ABSTRACTS

  • McLaughlin P, Chutinan K, Hunt K, McKendry JBR, Davies RA. Effects of hypoglycemia and alcohol on decision-making processes and neuromuscular coordination. Traffic Injury Research Foundation 7th Annual Meeting, May, 1970.
  • Matthay RA, Berger HJ, Davies RA, Loke J, Zaret BL. Right and left ventricular performance during steady state exercise in chronic obstructive pulmonary disease: Non-invasive assessment by radionuclide angiocardiography. Clin. Res. 27: 401A; 1979.
  • Matthay RA, Berger HJ, Loke J, Davies RA, Zaret BL. Augmentation of right ventricular performance by sustained-released theophylline in chronic obstructive pulmonary disease: Non-invasive assessment by radionuclide angiocardiography. Amer. Rev. Resp. Dis. 119: 194; 1979.
  • Matthay RA, Berger HJ, Davies RA, Loke J, Gottschalk A, Zaret BL. Effect of steady state exercise on right and left ventricular performance in chronic obstructive pulmonary disease, non-invasive assessment by radionuclide angiocardiography. Chest 77: 2; 1980 (suppl.).
  • Davies, R.A., Thakur, M., Berger, H., Wacker, F., Gottschalk, A., Zaret, B. Imaging of the inflammatory response to acute myocardial infarction in man using indium-111 labelled white blood cells. Circulation 59-60 (suppl. II): 268; 1979.
  • Berger H, Davies RA, Sands J, Lachman A, Alexander J, Boeowski J, Williams, B, Wacker, F, Gottschalk A, Zaret BL. Abnormal exercise left ventricular reserve in patients with chest pain, ischemic ECG exercise response and normal coronary arteries. Circulation 59-60 (suppl. II): 268; 1979.
  • Lewis S, Riba A, Davies RA, Berger H, Carocco C, Jaffee C. Ventricular geometry at rest as a predictor of exercise performance in aortic regurgitation: A combined echocardiographic and radionuclide study. Circulation 59-60 (suppl. II): 241; 1979.
  • Matthay R, Berger H, Davies RA., Loke J, Zaret B. Prolonged improvement in cardiac performance by oral long-acting theophylline in chronic obstuctive pulmonary disease. Circulation 59-60 (suppl. II): 107 ; 1979.
  • Davies RA, Laks H, Berger H et al. Follow-up radionuclide assessment of left ventricular function and perfusion in patients requiring intra-aortic balloon pump to wean from cardiopulmonary bypass. Am. J. Cardiol; 45: 488; 1980.
  • Davies RA, Thakur ML, Berger HJ, Wackers F, Gottschalk A, Zaret BL. Imaging the inflammatory response to acute myocardial infarction in man using biologically active indium-111 labelled leukocytes. Ann. Roy. Coll. Phys. Surg. 13: 111; 1980.
  • Davies RA, Thakur ML, Berger HJ, Wacker F, Gottschalk A, Zaret B. Indium-111 labelled autologous leukocytes (IN-WBC) for imaging inflammatory response to acute myocardial infarction (MI). J. Nucl. Med. 21: 89; 1980.
  • Berger HJ, Davies RA, Batsford WP, Gottschalk F, Zaret B. Beat to beat ssessment of left ventricular performance using a computerized nuclear probe: Validation, analysis of variability and initial study of ectopy. J. Nucl. Med. 21: 7; 1980.
  • Berger HJ, Wackers F, Mahler D, Davies RA, Matthay R, Zaret B. Right ventricular visualization on thallium-201 myocardial images in chronic obstructive pulmonary disease: Relationships to ventricular function and hypertrophy. Circulation 62: (suppl. III) 103; 1980.
  • Mahler DA, Berger H, Matthay RA, Wacker F, Davies RA, Zaret,BL. Right ventricular visualization on resting thallium-201 myocardial images in chronic obstructive pulmonary disease: Relationship to radionuclide right ventricular performance and ECG right ventricular hypertrophy. Amer. Rev. Resp. Dis. 123: 112 ; 1981.
  • Davies, RA, Morton B, Deimel J, Ganley D, Beanlands D.S. Correlation and variability of ejection fraction and wall motion with contrast left ventriculography and blood pool imaging. Canadian Cardiovascular Society, 155; 1981.
  • Cleman MW, Francis CK, Berger JJ, Davies RA, Giles RW, Black JR, Zito RA, Zaret BL. Normal left ventricular function responses to upright bicycle exercise in hypertension. Amer. J. Cardiol. 49: (No. 4, Part 2): 950; 1982.
  • Davies RA, Beanlands DS, Deimel J. Exercise thallium-201 myocardial imaging after inferior infarction to detect multivessel coronary artery disease. Clin. Invest. Med. 5: (suppl. 1):23; 1982.
  • Morton BC, Higginson LAJ, Tyrala M, Davies RA, Chambers RJ, Beanlands DS. Results of successful transluminal coronary angioplasty. Clin. Invest. Med. 5: (suppl. I):19; 1982.
  • Davies RA, Willis J, Morton B, Ascroft F, Higginson LAJ, Gulenchyn K, Beanlands DS. Comparison of thallium-201 imaging after dipyridamole and exercise in patients with single left anterior descending coronary artery disease. Clin. Invest. Med. 6: (suppl. I):20; 1983.
  • Morton BC, Higginson LAJ, Davies RA, Chambers RJ, Beanlands DS. Recognition of recurrent coronary stenosis following transluminal coronary angioplasty (PTCA). Clin. Invest. Med.6: (suppl. I):20; 1983.
  • Beanlands DS, Morton BC, Higginson LAJ, Williams WL, Davies RA. Same day discharge following percutaneous transfemoral left heart catheterization. Clin. Invest. Med.6: (suppl. I):19; 1983.
  • Davies RA, Denley H, Pomroy C, Noel L, Ascroft F, Gulenchyn K, Deimel J. Long-term human whole body thallium-201 washout characteristics following exercise. Eur. Heart J.5: (abstr. suppl. 1) 5: 81; 1984.
  • Davies RA, Willis J, Akyurekli Y, Ascroft F, Beanlands DS. Non-invasive comparison of ventricular function with atrioventricular sequential versus ventricular pacing in complete heart block. 3rd European Symposium on Clinical Cardiac Pacing, Torremolinosis, Spain; 1985.
  • Green M, Davies RA. Phase analysis of radionuclide ventriculograms in patients with ventricular tachycardia. Interamerican Congress of Cardiology, Vancouver; 1985.
  • Chan KL, Davies RA, Ascroft F, Tang A. Radionuclide assessment of left ventricular function in sepsis and septic shock. Interamerican Congress of Cardiology, Vancouver; (Dr. Chan, resident; Dr. Davies, supervisor); 1985.
  • Willis J, Davies RA, Akyurekli Y, Ascroft F, Beanlands DS. Non-invasive comparison of ventricular function with atrioventricular sequential versus ventricular pacing in complete heart block. Interamerican Congress of Cardiology, Vancouver; (Dr. Willis, research fellow; Dr. Davies, supervisor); 1985.
  • Higginson LAJ, Davies RA, Willis J, Temple V, Sheldrick K, Ascroft F Coronary reperfusion and its late effect on left ventricular function and regional blood flow in the pig. Interamerican Congress of Cardiology, Vancouver; 1985.
  • Broecker L, Dix G, Runstedler BF, Davies RA, Keon WJ. Role of perfusion term in total heart transplantation. Canadian Council of Cardiovascular Perfusionists (Affiliated with CCS Meeting), Halifax; 1985.
  • Higginson L, Davies RA, Willis J, Temple V, Sheldrick K, Marquis F. Ventricular function and blood flow one month after coronary reperfusion in the anesthetized pig. Clin. Invest. Med. 8:(suppl. B):65; 1985.
  • Habibi H, Davies RA. Criteria for ST segment response in diagnosis of coronary artery disease after intravenous dipyridamole with thallium-201 imaging. (Poster) Abstract (poster) Canadian Cardiovascular Society Meeting, Halifax; (Dr. Habibi, Research Fellow; Dr. Davies, supervisor); October 1985.
  • Davies RA, Koshal A, Jindal S, Walley V, Runstedler B, Green M, Morton B, Chan K, Dafoe W, Saginur R, Beanlands DS, Keon WJ. The clinical experience of the University of Ottawa Heart Institute. (poster). International Society for Heart Transplantation, New York; April 1986.
  • Davies RA, Walley Virginia M. Valve-like appearance of muscular crista terminalis separating superior vena cava and right atrium on radionuclide angiocardiogram. X World Congress of Cardiology, Washington; 1986.
  • Davies RA, Habibi HJ, Marquis JF. Comparison of diagnostic criteria for coronary artery disease after dipyridamole with thallium-201 imaging. Clin Invest Med, abstract # 761, Vol 9, suppl 3:A122; 1986.
  • Davies RA, Habibi H. Diagnostic criteria for coronary artery disease after intravenous dipyridamole with thallium-201 imaging. X World Congress of Cardiology, Washington; (Poster) (Presented by Dr. Habibi, research fellow); 1986.
  • Green MS, Davies RA. Verapamil improves ability of phase imaging to localize accessory pathways. X World Congress of Cardiology, Washington; 1986.
  • Davies RA, Runstedler B, Koshal A, Walley V, Green M, Morton B, Jindal S, Beanlands DS, Keon W.J. Temporary diastolic non-compliance with preserved systolic function after heart transplantation. Clin Invest Med, abstract # 1050, Vol 9, suppl 3:A168, 1986.
  • Davies RA, Walley VM, Marquis JF. Photon deficient zone separating superior vena cava and right atrium during atrial contraction on radionuclide angiocardiography simulating valve action. Clin Invest Med, abstract #R750, Vol 9, suppl 3:A120, 1986.
  • Chan K, Davies RA, Barrie M, Keon WJ. Incidence of valvular dysfunction in patients following orthotopic cardiac transplantation. Clin. Invest. Med. Suppl 9 (3): A71; 1986.
  • Davies RA, Green MS, Marquis JF. Phase imaging after intravenous verapamil improves localization of accessory pathways in Wolff-Parkinson-White syndrome. Clin Invest Med, abstract #R749, Vol 9, suppl 3:A120 ; 1986.
  • Habibi J, Davies RA, Marquis F. Dipyridamole thallium-201 imaging after myocardial infarction to detect residual ischemia. (poster) Canadian Cardiovascular Society, Ottawa, (Dr. Habibi, research fellow; Dr. Davies, supervisor); 1986.
  • Klein AL, Marquis JF, Higginson LAJ, Morton BC, Williams WL, Davies RA, Beanlands DS. Intravenous dipyridamole induced myocardial ischemia during percutaneous transluminal coronary angioplasty. Texas Heart Institute; 1986.
  • Tang ASL, Thomson JG, Chan KL, Higginson LAJ, Davies RA, Kraag GR. Left ventricular function in ankylosing spondylitis patients without valvular disease. Clin Invest Med Suppl 1986, 9, (3): A7; 1986.
  • Davies RA, Koshal A. Walley V. Runstedler B, Green M, Morton B, Jindal S, Beanlands D, Keon WJ. Effect of rejection on systolic and diastolic function after heart transplantation, Vol 5, pg 372, September/October 1986. Program Issue: The International Society for Heart Transplantation; New Orleans, Louisiana; March 1987.
  • Habibi H, Ruddy TD, Spencer PC, Davies RA. Prognosis in patients with strongly positive exercise electrocardiograms and normal thallium-201 scintigrams. J Nuc Med 28:643; 1987.
  • Davies RA, Ruddy TD, Ballinger JR, Spencer PC, Habibi H. Comparison between metabolic and perfusion imaging in coronary artery disease. Clin Invest Med Vol 10, No. 4, 53; 1987.
  • Davies RA, Habibi J, Calvin J, Ruddy TD, Marquis JF, Barber G, Scobie TK, McPhail N. High prevalence of coronary artery disease in patients with peripheral vascular disease detected by dipyridamole thallium-201 imaging. Clin Invest Med Vol 10, No 4: 54; 1987.
  • Davies RA, Ruddy TD, Ballinger JR, Spencer PC. Metabolic versus perfusion imaging in coronary artery disease. Clin Invest Med Vol. 10, No. 5: 34; 1987.
  • Ballinger JR Gerson B, Gulenchyn KY, Ruddy, TD, Davies RA. Optimal Tc-99m RBC labeling technique for use in patients treated with doxorubicin. Clin Nucl Med Vol 13, No. 3:169; 1987.
  • Koshal A, Beanlands DS, Davies RA, Nair R, Allan K, Keon WJ Urgent surgical reperfusion in acute evolving myocardial infarction - a randomized controlled study. Clin Invest Med Vol. 10, No. 5:36; 1987.
  • Ruddy TD, Habibi H, Spencer PC, Davies RA. Prognostic value of normal thallium scintigrams in patients with strongly positive exercise electrocardiograms. Clin Invest Med, Vol. 10, No. 5:35; 1987.
  • Koshal A, Beanlands DS, Davies RA, Nair RC, Keon WJ. Urgent surgical reperfusion in acute evolving myocardial infarction - A randomized controlled study. Circulation Vol 76, suppl IV: 29; 1987.
  • Ruddy TD, Habibi H, Spencer PC, Davies RA. Prognostic value of normal thallium scintigrams in patients with strongly positive exercise electrocardiograms. Circulation Vol 76, Suppl IV, pg IV: 156, 1987.
  • Davies RA, Ruddy TD, Ballinger JR, Spencer PC, Habibi H. Differences between metabolic imaging with I-123-p-phenylpentadecanoic acid and perfusion Thallium-201 imaging in coronary artery disease. J Nucl Med 28:4; 669, 1987.
  • Davies RA, Haider M. Analysis of septal perfusion on exercise thallium-201 imaging to detect left anterior descending coronary artery disease after inferior myocardial infarction. 1987, pg 82 (English), pg 83 (French), Clin Invest Med: 11(3); 1988.
  • Davies RA, Ruddy T, Ballinger J, Spencer PC. Metabolic imaging with I-123-p-phenylpentadecanoic acid versus perfusion thallium-201 imaging in normals and patients with coronary artery disease. Clin Invest Med 11 (3): B9; 1988.
  • Ballinger JR, Gerson B, Ruddy TD, Davies RA Plasma kinetice of (I-124) 15-(p-iodophenyl) pentadecanoic acid (IPPA): Effects of coronary artery disease (CAD) and level of exercise. Pg 90 (English), pg 91 (French), Clin Invest Med 11:B9; 1988.
  • Davies RA, Ruddy TD, Ballinger JR, Spencer P, Habibi, H. Exercise myocardial imaging: Comparison between iodine-123-p-phenylpentadecanoic acid and thallium-201. Radioactive Isotopes in clinical Medicine and Research, 18th International Symposium, Badgastein, Austria; 1988.
  • Rose MI, Sananes R, Davies RA, Keon WJ. MMPI profiles of patients undergoing cardiac transplantation assessment. 23rd Annual Symposium on Recent Developments in the use of MMPI, MMPI Conference, St. Petersburg, Florida; 1988.
  • Strauss BJ, Ruddy TD, Marquis JF, Davies RA, Morton BC, Higginson LA, Williams WL, Adey CK, Beanlands DS. Prediction of coronary artery restenosis following angioplasty in patients with unstable angina using stress thallium imaging. Pace 11 (6); 927 ; 1988.
  • McPhail NV, Ruddy TD, Calvin JE, Davies RA, Barber GG, Cole CW, Sauve M, Vigus LL. A comparison of dipyridamole thallium imaging and exercise testing in the prediction of postoperative cardiac complications in patients requiring arterial reconstruction. New England Society for Vascular Surgery, 15th Annual Meeting, Montreal; 1988.
  • Sauve MD, Ruddy TD, McPhail NV, Calvin JE, Davies RA, Vigus LL, Barber GG, Cole CW, Scobie TK. Noninvasive prediction of cardiac complications in patients undergoing vascular surgery. Can J Surg; (4) 31; 1988.
  • White M, Ruddy TD, Davies RA, Vigus LL, Spencer PC, Cooper EJ, Marquis JF, Ballinger JR. Dipyridamole metabolic imaging for the detection of coronary artery disease. Clin Invest Med, Vol 11, No.4, Abstract #25; 1988.
  • Ruddy TD, McPhail NV, Davies RA, Calvin JE, Vigus LL, Sauve, MD, Barber GG, Cole CW, Scobie T. Prediction of cardiac complications in patients undergoing vascular surgery. Clin Invest Med Vol 11, No. 4, Abstract # 171; 1988.
  • Strauss BH, Ruddy TD, Marquis JF, Habibi H, Davies RA, Morton BC, Higginson LAJ. Williams WL, Martin H, Vigus LL, Beanlands DS. Prediction of restenosis following angioplasty for unstable angina. Clin Invest Med, Vol 11, No 4, Abstract # 171; 1988.
  • Ruddy TD, Sauve MD, McPhail NV, Calvin JE, Davies RA, Vigus LL, Barber GG, Cole CW, Scobie TK. Noninvasive prediction of cardiac complications in patients undergoing vascular surgery. Chest: 94, 65S; 1988.
  • Yang L, Ruddy TD, Davies RA, Ballinger JR. Effects of exercise on myocardial kinetics of iodine-123-phenylpentadecanoic acid. J Nucl Med 30(5); 829; 1989.
  • White M, Ruddy TD, Gulenchyn K, Davies RA, Vigus L, Spencer PC, Cooper E, Marquis J, Ballinger J. Detection of coronary artery disease with iodine-123-phenylpentadecanoic acid tomography and dipyridamole infusion. J Nucl. Med. 30(5); 760; 1989.
  • Ruddy TD, White M, Gulenchyn KY, Spencer PC, Cooper EJ, Baird MG, MarquisJFBallinger JR, Davies R.A.: Detection of coronary artery disease with metabolic scintigraphy using iodine-123-phenylpentadecanoic acid and dipyridamole induced hyperemia. Eur. J. Nucl. Med. 35(8); 469; 1989.
  • Ruddy TD, Gulenchyn KY, Ascah KJ, Williams WL, Spencer PC, Kearns SA, Ballinger JR, Davies RA. Comparison of In-111 antimyosin antibody and Tc-99m pyrophosphate imaging of myocardial necrosis. Eur. J. Nucl. Med. 15(8); 470; 1989.
  • Ruddy TD, White M, Davies RA, Vigus LL, Spencer PC, Cooper EJ, Baird MG,. Marquis JF, Ballinger JR. Iodine-123-phenylpentadecanoic acid tomography following dipyridamole infusion for the detection of coronary artery disease. J. Am. Coll. Cardiol.13(2);99A; 1989.
  • Ruddy TD, McPhail NV, Calvin JE, Davies RA, Vigus LL, Barber GG, Cole CW.: Comparison of exercise testing, dipyridamole thallium imaging and gated blood pool scanning for the prediction of cardiac complications following vascular surgery. J. Am. Coll. Cardiol. 13(2); 149A; 1989.
  • Sauve MD, Ruddy RD, McPhail NV, Calvin JE, Davies RA, Vigus LL, Barber GG, Cole, CW. Superiority of dipyridamole thallium over clinical scales in estimating the cardiac risk of vascular surgery. Clin Res. 37(2); 325A; 1989.
  • Yang LD, Ruddy TD, Davies RA, Williams JW, Ballinger JR. Effects of exercise on myocardial kinetics of iodine-123-phenylpentadecanoic acid. Clin. Invest. Med. 12(5); C71; 1989.
  • Ruddy TD, Ascah KJ, Gulenchyn KY, Giannoccaro PJ, Williams WL, Spencer PC, Kearns SA, Ballinger JR, Davies RA. Detection of myocardial salvage with combined antimyosin and thallium imaging. Circ. 80(4); II308; 1989.
  • McPhail NV, Ruddy TD, Calvin JE, Davies RA, Barber GG, Cole CW, Vigus LL. A comparison of dipyridamole thallium imaging and exercise testing in the prediction of postoperative cardiac complications in patients requiring arterial reconstruction. J. Vasc. Surg.10; 51; 1989.
  • Davies RA, Haider MA. Application of a relational database management language and artificial intelligence to a heart transplant computer program. J Am Coll Cardiol 15(2); 262A;, 1990.
  • Giannoccaro PJ, Ruddy TD, White M, Gulenchyn KY, Smith C, Davies RA, Marquis JF, Ballinger JR. Dipyridamole metabolic scintigraphy using I-123-phenylpentadecanoic acid vs dipyridamole thallium-201 perfusion imaging for the detection of coronary artery disease. J Am Coll Cardiol 15(2); 20A; 1990.
  • Davies RA, Haider MA. Heart Transplant Database Management Software. Clin Invest Med 13; B83; 1990.
  • Davies RA, Holden RL, Ooi TC and Moher D. Hyperlipidemia following heart transplantation improved with gemfibrozil. Clin Invest Med 13; B83; 1990.
  • Davies RA, Haider MA. Heart Transplant Database Management Software. J Am Coll Cardiol Vol. 15, No. 2:262A; 1990.
  • Davies RA, Holden RL, Ooi TC and Moher D. Hyperlipidemia following heart transplantation improved with gemfibrozil. Clin Invest Med 13; C56; 1990.
  • Giannoccaro PJ, Ruddy TD, White M, Gulenchyn KY, Smith C, Davies RA, Marquis JF, Ballinger JR.Dipyridamole metabolic scintigraphy using I-123 phenylpentadecanoic acid vs dipyridamole thallium-201 perfusion imaging for the detection of coronary artery disease. J Am Coll Cardiol Vol.15, No.2:220A; 1990.
  • Walker SW, Gulenchyn KY, Smith C, Davies RA, Ruddy TD. Lesion volume determination by SPECT: Analysis of processing factors for Tc-99m and In-111. Society of Nuclear Medicine Eastern Great Lakes Chapter, Niagara Falls; April 1990.
  • Walker SW, Gulenchyn KY, Davies RA, Ruddy TD. Lesion volume determination by SPECT: Analysis of processing factors for Tc-99m and In-111. 5th World Congress of Nuclear Medicine and Biology, Montreal; August 1990.
  • Boyd D, Koshal A, Masters R, Davies RA, Keon WJ, Preservation of hemodynamic function in donor hearts transported at 12oC. Clin Invest Med 13; C36; 1990.
  • Simpson B, Smith C, Davies RA, Ruddy TD, Gulenchyn KY. Scatter correction for dual isotope imaging of thallium-201 and technetium-99m; (B. Simpson, Nuclear Medicine Technology Student; Dr. Davies, supervisor); J Nuc Med Tech 19(2); 119:1991.
  • Simpson B, Smith C, Davies RA, Ruddy TD, Gulenchyn KY. Dual isotope imaging of thallium-201 and technetium-99m requires scatter correction. The Eastern Great Lakes Chapter, Society of Nuclear Medicine; (B. Simpson, Nuclear Medical Technology student, Dr. Davies, supervisor); Niagara Falls, New York; April 1991.
  • Burns RJ, Fung A, Iles S, Davies RA, Daigneault L, Lalonde L, Hong Tai Eng F.: Exercise Tc-99m-Teboroxime cardiac SPECT: Results of a Canadian multicentre trial. J Nuc Med 32(5); 119;1991.
  • Davies RA, Simpson B, Smith C, Gulenchyn KY, Ruddy TD. Scatter correction for dual isotope imaging of technetium-99m compounds and thallium-201. Eur Heart J 12:209; 1991.
  • Davies RA, Smith C, Jamal N, Simpson B, Gulenchyn KY, Ruddy TD. Simultaneous dual isotope rest/stress myocardial perfusion imaging with thallium-201 and Tc-99m MIBI. Eur Heart J 12:207; 1991.
  • Davies RA, Smith C, Jamal N, Simpson B, Gulenchyn KY, Ruddy TD. Simultaneous dual isotope rest/stress myocardial perfusion imaging. Can J Cardiol Vol 7, Suppl A; 97A:1991.
  • Burns RJ, Fung A, Iles S, Davies RA, Daigneault L, Lalonde L, Hong Tai Eng F.: Exercise Tc-99m-Teboroxime cardiac SPECT: Results of a canadian multicentre trial. Can J Cardiol Vol 7 Suppl A; 98A; 1991.
  • Davies RA, Smith C, Jamal N, Simpson B. Gulenchyn KY, Ruddy TD. Simultaneous rest/stress myocardial perfusion imaging. Circ Suppl II Vol 84; 4:II-304; October 1991.
  • Masters RG, Hendry PJ, Mussivand T, Davies RA, Walley, VM, Keon WJ. Influence of priority status on outcome of cardiac transplantation. Can J Cardiol Vol 8 Suppl B; 116B; 1992.
  • Struthers C, Masters R, Davies RA. Current Functional Status of Recipients Following Staged Heart Transplantation with the Total Artificial Heart. Canadian Association of Transplantation Fall Conference & Annual General Meeting, Ottawa; September 1992.
  • Davies RA. Safety and efficacy of pravastatin after heart transplantation: Preliminary patient studies. XI International Symposium on Drugs Affecting Lipid Metabolism, Florence, Italy, abstract #A18; May 1992.
  • Masters R, Hendry P, Keon W, Koshal A, Davies RA. Symbion TAH for cardiogenic shock. American Society for Artificial Organs 38th Annual Meeting Nashville, Tennessee, 1992.
  • Masters RG, Hendry PJ, Davies RA, Mussivand T, Struthers C, Keon WJ. Influence of Priority Status on Outcome of Cardiac Transplantation. International Society of Cardiothoracic Surgeons, Third World Congress, Salzburg, Austria; 1993.
  • Halle A et al (Dr. RA Davies is local principal investigator, Ottawa). PTCA, Directional Atherectomy and Coronary Artery Bypass Surgery in Cardiac Transplant Patients: Multicenter Findings. J Am Coll Cardiol vol.21, No.2:333A; 1993.
  • Samson-Booth N, Davies RA. Angina after heart transplantation. (Samson-Booth, exercise techologist; Dr. Davies, supervisor). Physician Case Report. J Am Coll of Sports Medicine Vol. 25; No. 5; S117; 1993.
  • Auclair F, Masters R, Davies RA, Jessamine P, Keon WJ, Saginur R. Systemic Inflammatory Response Syndrome in Heart Transplantation Patient with Bacteremia. 18th International Congress of Chemotherapy, Stockholm, Sweden; 1993.
  • Davies RA, Masters R, Struthers C. Pravastatin is Safe and Effective for Hypercholesterolemia After Heart Transplantation. Clin Invest Med Suppl Vol.16, No.4; B142; 1993.
  • Davies RA, Watson I, Manion D, Struthers C, Auclair F, Diaz-Mitoma F, Masters R, Saginur R. Cytomegalovirus Immune Globulin Interferes with Serological Testing After Heart Transplantation. Clin Invest Med Suppl Vol.16, No.4; B142; 1993.
  • Petsikas D, Davies RA, Masters R, Struthers C, Hendry P, Keon WJ. Functional Recovery After Urgent Heart Transplantation. (Dr. Petsikas, surgical resident; Dr. Davies, supervisor). Can J Cardiol Vol 9; Suppl E;136E; 1993.
  • Yvorchuk K, Davies RA, Chan K. Validation of a New Automatic Edge Detection Algorithm in the Measurement of Left Ventricular Ejection Fraction by comparing with Radionuclide Angiography and a Combined Echo-Doppler Method. Can J Cardiol Vol 9; Suppl E: 119E; 1993.
  • Masters RG, Davies RA, Labow RS, Hendry PJ, Harmsen E, Waghray G, Meek E. Myocardial Ca++ Uptake in Cardiac Transplantation. Can J Cardiol Vol 9; Suppl E:136E. October 26 – 30; 1993.
  • Masters RG, Hendry PJ, Davies RA, Mussivand T, Struthers C, Keon WJ. Influence of Priority Status on Outcome of Cardiac Transplantation. Proceedings of the 3rd World Congress of ISCTS; January 1993.
  • Struthers C, Masters R, Davies RA. Current Functional Status of Recipients Following Stage Heart Transplantation with the Total Artificial Heart. CTS/CAT Conference, Whistler B.C.; September 1994.
  • Lee S, Veinot JP, Smith S, Davies RA, Walley VM. External Cardioversion - Related Cardiac Damage: An Unusual Case. Ontario Association of Pathologists 57th Annual Meeting, Niagara on the Lake, Ontario; 1994.
  • Lee AP, JP Veinot, Davies RA, Keon WJ, Walley VM. A Fenestrated Aortic Valve Contributing to Iatrogenic Insufficiency-Post Mitral Valve Replacement. Ontario Association of Pathologists 57th Annual Meeting, Niagara on the Lake, Ontario; 1994.
  • Leenen FHH, Davies RA, Fourney A. B-Selective vs Non-Selective B-Blockade and Exercise-Hemodynamics in Cardiac Transplant vs Essential Hypertensive Patients. Clin Invest Med Vol 14, Suppl 4:B14; 1994.
  • Masters RG, Hendry PJ, Davies RA, Smith S, Walley VM, Keon WJ. Bridge to Cardiac Transplantation for Profound Cardiovascular Collapse. Can J Cardiol Vol 10 Suppl C:136C;, 1994.
  • Ibrahim M, Masters RG, Hendry PJ, Davies RA, Smith S, Struthers C, Keon WJ. Determinants of Early Survival Following Cardiac Transplantation. Can J Cardiol Vol 10 Suppl C:137C; 1994.
  • Struthers C, Smith S, Masters R, Davies RA and Donat E. Effects of elevated Pulmonary Vascular Resistance and Pulmonary Artery Pressures on Patient Morbidity Post Heart Transplantation. CCS/CCCN Annual Meeting. Conf. Proceedings; 1994.
  • Hendry PJ, Masters RG, Davies RA, Smith SJ, Walley VM, Keon WJ. Mechanical Assistance for Cardiogenic Shock: A Canadian Perspective. Submitted to Amer Heart Assoc, Dallas, Texas; November 1994.
  • Hendry PJ, Masters RG, Davies RA, Smith S, Walley VM, Struthers C, Mussivand T, Lavallee g, Blohon R, Keon WJ. The Artificial Heart and Ventricular Device Program: A 10 Year Experience at the University of Ottawc Heart Institute. Submitted as poster. Circulatory Support 1994 3rd International Conference, Chicago; October 1994.
  • Beanlands R, Keon W, Beanlands DS, Marcel Y, Gulenchyn K, Tuddy T, Davies RA, Chamberlain M, Hartman N, MacKee B, Smith S, MacPherson R, Davies RF, Hendry, P, Masters R. Application of cardiac PET in Canada. Ottawa Life Sciences Week; 1994.
  • Davies RA, Patient Oriented Workstation Design Towards an Electronic Patient Record >95 Symposium, Orlando, Florida; March 18, 1995.
  • Masters RG, Hendry PJ, Davies RA, Smith S, Struthers C, Keon WJ: Pre-operative Determinants of Hospital Survival Following Cardiac Transplantation. Int. Soc. for Heart and Lung Tx 15th Annivesary meeting and Scientific Sessions San Francisco, CA; April 1995.
  • Hendry PJ, Masters RG, Davies RA, Smith S, Struthers, Keon WJ: Mechanical Bridge to Transplantation for Cardiogenic Shock. Submitted to Int. Soc. for Heart and Lung Tx 15th Anniversary meeting and Scientific Sessions, San Francisco, CA; April 1995.
  • Davies RA and Smith SJ, Struthers C, Masters RG, Hendry PJ, Cheung T, Sherrard H, Higginson LAJ, Keon WJ. Patient Database Management Software ©. Accepted for both oral and slide presentation to the Ottawa Life Sciences Conference; October 17 & 18, 1995.
  • Ruddy TD, Smith SJ, Dalipaj MM, Chauhan VS, Aung MT, Aubrey BA, Davies RA, Hartman NG, Veinot JP, Beanlands RSB. Evaluation of Heart Transplant Rejection and Ventricular Function with Technetium-99m Antimyosin Imaging. Can J Cardiol Vol 11 [suppl 3]:71E; 1995.
  • Donat ME, Smith SJ, Masters RG, Struthers C, Davies RA, Hendry PJ, Keon WJ. Preoperative Hemodynamics Do Not Predict Early or Late Outcome in Cardiac Transplantation. Can J Cardiol Vol 11 [suppl 3]:72E; 1995.
  • Beanlands RSB, deKemp RA, Culbert P, Smith SJ, Hendry PJ, Davies RA, Bedard P, Nahmias C, Firnau G, Bowen B, Coates G, Chirakel R, Fallen E, Ruddy TD. Myocardial Glucose Metabolism in Severe Ischemic Left Ventricular Dysfunction. Can J Cardiol Vol 11 [suppl 3]:104E; 1995.
  • Kim H, Tam JW, Yvorchuk K, Davies RA, Chan KL. Effect of Imaging Plane and LV Function on Albunex Echocardiography. Can J of Cardiol Vol. 11 [suppl E]:97E; 1995.
  • Beanlands RSB, deKemp RA, Culbert P, Smith S, Hendry P, Davies RA, Bedard P, Nahmais C, Firnau G, Bowen B, Coates G, Chirakel R, Fallen E, Ruddy TD. Myocardial Glucose Metabolism in Severe Ischemic Left Ventricular Dysfunction. Can J of Cardiol Vol 11 [suppl E]:104E; 1995.
  • Mussivand T, Boyd D, Chambers J, Chow L, Davies RA, Diguer M, Hendry P, Hirsh J, Ho C, Holmes K, Hum A, Irvine J, Keaney M, Kieser T, Koshal A, Labow R, Laplante R, Lavallee G, Masters R, Meuller R, Milligan L, Rajagopalan K, Rubens F, Ruddy T, Walley VM, Keon WJ. In Vivo Assessment of a Totally Implantable Intrathoracic Ventricular Assist Device. Can J of Cardiol Vol 11 [suppl E]:140E; 1995.
  • Latter D, Rivard M, Carrier M, Jolain B & Cascade Investigators Davies RA. Determinants of Graft Accelerated Atherosclerosis in Canadian Heart Transplant Recipients. Can J Cardiol; 11 (suppl E): 139E; 1995.
  • Ibrahim M, Masters RG, Henrry PJ, Davies RA, Smith S, Struthers C, Walley VM, Keon WJ. Determinants of Hospital Survival after cardiac transplantation, Can Transplant Soc; Halifax; Apr 19- 21, 1995.
  • Yvorchuk KJ, Davies RA, Chan KL. Effect of imaging plane and LV function on Albunex echocardiography. Can J Cardiol; 11 (suppl. E): 30E; 1995.
  • Semelhago LC, Masters RG, Hendry PJ, Davies RA, Smith S, Struthers C, Keon WJ. Influence of recipient age on outcome of cardiac transplantation. Royal College of Physicians and Surgeons, Halifax, Nova Scotia; 1996.
  • Ruddy TD, Smith SJ, Dalipaj MM, Chauhan VS, Aung MT, Aubrey BA, Davies RA, Hartman NG, Veinot JP, Beanlands RSB. Evaluation of Heart Transplant Rejection and Ventricular Function with Technetium-99m Antimyosin Imaging. JACC; 27:2-24A; 1996.
  • Ruddy TR, Smith SJ, Dalipaj MM, Vijay S, Aung M, Aubrey BA, Davies RA, Hartman N, Veinot JP, Beanlands. Evaluation of Heart Transplant Rejection and Ventricular Function with Technetium-99m Antimyosin Imaging. JACC; 240:968-16; 1996.
  • Davies RA. Matching Patient and User Identifiers. >Toward an Electronic Patient Record= ‘96 symposium, San Diego, California. Symposium Proceedings, Volume 2: 484-485; May 1996.
  • Davies RA, Chairman: Session on >Information Needs for Integrated Health Delivery Systems= at the >Toward and Electronic Patient Record= >95 Symposium San Diego, California; May 17, 1996.
  • Davies RA, Samson-Booth N, Ruddy TD, Beanlands R, Gulenchyn KY, Chamberlain M. Safety of Delegation of Dipyridamole Testing to Exercise Technologists. Can J. Cardiol. Vol 12, Suppl E: 161E; 1996.
  • Davies RA, Rivard M, Pflugfelder P, Teo K, Jolain B, Champagne F, Contandriopoulos A-P,Carrier M, Latter D, Chartrand C, Daly P, Gudas V, Poirier N, Sullivan J, Kostuk W. Heart Transplantation in Canada and Determinants of Survival. CCS Annual meeting Oct-Nov 96, Montreal.Can J. Cardiol, Suppl E: 153E; 1996.
  • Davies RA, Rivard M, Pflugfelder P, Teo K, Jolain B, Champagne F, Contandriopoulos A-P, Carrier M, Latter D, Chartrand C, Daly P, Gudas V, Poirier N, Sullivan J, Kostuk W. Heart Transplantation in Canada and Determinants of Survival. Can. J. Cardiol; 12 (Supple E) pg. 153E #296; 1996.
  • Davies RA, Rivard M, Pflugfelder PW, Jolain B. Heart Transplantation and Determinants of Early and Late Mortality. ACC 46th Scientific Session 1997. JACC; 28A: 910-178; 1996.
  • Beanlands RS, deKemp RA, Smith S, Aung M, Aubrey B, Davies RA, Ruddy TD. Directing Therapy in Patients with Severe Ventricular Dysfunction Using FDG PET. 3rd International Conference of Nuclear Cardiology April 1997, Florence, Italy. Journal of Nuc. Cardiol; 4(1) S.18; 1997.
  • Davies RA. Clinical Use of Multimedia in a Patient Database. The 7th World Congress of Intensive and Critical Care Medicine; Ottawa; 97; July 1, 1997.
  • Leenen FHH, Davies RA, Fourney A. Cardiac Responses to β-Agonists in Cardiac Transplant Patients. The Canadian Society for Clinical Investigation; Vancouver, BC; September 25-28, 1997.
  • FHH Leenen, RA Davies, A Fourney. Cardiac Responses to B-Agonists in Cardiac Transplant Patients. Canadian Cardiovascular Society Meeting, Winnipeg, Manitoba October 5-9, 1997. Can. J. Cardiol; 13 (Suppl C): 75C #9; 1997.
  • RSB Beanlands, G Nichol, DE Visentin, S Smith, RA deKemp, P Hendry, R Masters, RA Davies, MT Aung, BA Aubrey, TD Ruddy. Potential for Cost Savings with FDG PET Imaging in Patients Being Considered for Cardiac Transplantation. Canadian Cardiovascular Society Meeting, Winnipeg, Manitoba, October 5-9, 1997; Can J Cardiol; 13 (suppl C): 99C #111; 1997.
  • RSB Beanlands, G Nichol, DE Visentin, S Smith, RA deKemp, P Hendry, R Masters, RA Davies, MT Aung, BA Aubrey, TD Ruddy. Potential for Cost Savings with FDG PET Imaging in Patients Being Considered for Cardiac Transplantation. Presented to the American Heart Association 70th Scientific Session; Circulation (Suppl); 96 (8); I13 #71; 1997.
  • Lonn EM, Bosch J, Pogue J, Dagenais G, Yosuf S, for the HOPE Investigators (Davies RA), Left Ventricular Hypertrophy is a Potent Risk Factor for Adverse Cardiovascular Outcomes, Canadian Cardiovascular Society Meeting, Winnipeg, October 5-9, 1997; Can J Cardiol ; 13 (Suppl C): 106C #144; 1997.
  • Masters R., Mussivand T., Smith S., Davies R.A., Struthers C., RN, Finlay S., RN, Keon W.J. Circulatory support for cardiogenic shock due to acute myocardial infarction. J. Heart and Lung Transplant; 17 (1) #199 P. 93; 1998.
  • Hendry P, Masters R, Mussivand T, Smith S, Davies RA, Struthers C., RN, Finlay S., RN, Keon WJ. Circulatory support for cardiogenic shock due to acute myocardial infarction. International Society for Heart and Lung Transplantation, Chicago, Illinois; April 15-18, 1998.
  • Zitouni LM, Russell S, Mayhew AD, Davies RA. Identifying the early rehabilitation needs of the cardiac transplant recipient, Canadian Physiotherapy Association (CPA) National Congress, St Johns Newfoundland; June 25- 29, 1998.
  • Hendry PJ, Masters RG, Mussivand T, Smith S, Davies RA, Keon WJ. Artificial Hearts for Cardiogenic Shock Due to Acute Myocardial Infarction. Canadian Cardiovascular Society Meeting, October 20-24, 1998, Ottawa. Canadian Journal of Cardiology Vol 14(Suppl F) September 1998.
  • Carrier M, Rivard M, Kostuk W, Latter D, Jolain B, Daly P, Davies RA, Teo K, Gudas V, Sullivan J, and Investigators of the CASCADE Study; Montreal. Canadian Cardiovascular Society Meeting, Ottawa; October 23, 1998; Can J Cardiology Vol 14(Suppl F) September 1998.
  • Carrier M, Rivard M, Kostuk W, Latter D, Jolain B, Daly P, Davies RA, Teo K, Gudas V, Sullivan J and Investigators for the CASCADE Study, The Canadian Study of Cardiac Transplant Atherosclerosis, Submitted to the Canadian Cardiovascular Society Meeting October 20- 24, 1998.
  • Davies, RA, Masters RG, Veinot JP, Smith SJ, deBold AJ. Natriuretic peptide release in cardiac allograft rejection. The Canadian Cardiovascular Society Meeting October 20-24, 1998.
  • Nagi KS, Davies RA, Struthers C, Saginur R, Masters R, Hendry P, Elsaadany S, Smith S. Patterns of practice across Canadian cardiac transplant centres. The Canadian Cardiovascular Society Annual Meeting, Ottawa, October 20- 24, 1998.
  • Hendry PJ, Masters RG, Mussivand TV, Smith SJ, Davies RA, Finlay S, Keon WJ. Circulatory support for cardiogenic shock due to acute myocardial infarction: A Canadian Experience. Can J Cardiol. 15(10): 1090-1094; 1999.
  • Davies RA, Master RG, Veinot JP, Smith SJ, Hendry PJ, deBold A. Natriuetic peptide release predicts cardiac transplant rejection and may be mediated by cytokine production. Accepted for the American Society of Transplant Physicians 18th Annual Scientific Meeting May 15-19, 1999. Transplantation; Volume 67, Number 7:S267; April 15, 19999.
  • Mussivand T, Hendry P, Masters R, Bourke M, Mueller R, Beanlands D, Smith S, Davies RA, Ruddy T, Ascah K, Keaney M, Kilbourn S, Guiraudon G, Keon W. Preparations for clinical utilization of the Canadian artificial Heart (Heartsaver VAD). Can J Cardiol;15:127D; 1999.
  • Davies, RA, Veinot J, Smith S, Struthers C, Hendry P, Masters. Outcome of Heart Transplantation for Giant Cell Myocarditis. Can J Cardiol 16 Suppl F: 176F; 2000.
  • Healey, JS, Smith SJ, Davies RF, Davies RA, Ooi DS. Prognostic Value of Troponin T and Troponin I in Patients with Heart Failure. The Canadian Cardiovascular Society; Vancouver, BC; October 29-November 1, 2000.
  • Healey JS, Smith SJ, Davies RF, Davies RA, Ooi DS, Prognostic Value of Serum Troponin T and Troponin I in Patients with Heart Failure. Heart Failure Society of America 4th Annual Scientific Meeting; Boca Raton, Florida; September 2000.
  • Healey JS, Smith SJ, Davies RF, Davies RA, Ooi DS. Prognostic Value of Serum Troponin T and Troponin I in Patients with Heart Failure. American Heart Association. Circulation 102, No 18, 3768; 2000.
  • Davies, RA, Veinot J, Smith S, Struthers C, Hendry P, Masters R. Outcome of Heart Transplantation for Giant Cell Myocarditis. Canadian Cardiovascular Congress; Vancouver, BC; October 29 to November 1, 2000.
  • Hendry PJ, Masters RG, Davies RA, Struthers C, Lavallee, Glasgow I, Mussivand T, Keon WJ. Mechanical circulatory support for end-stage heart failure: The Ottawa Heart Institute experience, 6th Symposium World Artificial-Organ, Immunology and Transplantation Society (WAITS), Ottawa, Canada; August 2001.
  • Hendry PJ, Masters RG, Davies RA, Struthers C, Lavallee, Glasgow I, Mussivand T, Keon WJ. Use of mechanical circulatory support devices in pediatric patients: The Ottawa Heart Institute Experience. 6th Symposium World Artificial-Organ, Immunology and Transplantation Society (WAITS) Meeting, Ottawa; August 17-19, 2001.
  • Struthers C, Davies RA, Hendry P, Mussivand T, Masters R, Reeves E. Mechanical support for heart failure Patients: Summary of Past Experiences and a Look into the Future, 6th Symposium World Artificial-Organ, Immunology and Transplantation Society (WAITS) Meeting, Ottawa; August 17-19, 2001.
  • Davies, RA, Hendry PJ, Masters RG, Struthers C, Veinot JP, Mussivand T, Keon WJ. Seventeen year experience with heart transplantation at the Ottawa Heart Institute: Comparison with Benchmark Canadian Results. 6th Symposium World Artificial-Organ, Immunology and Transplantation Society (WAITS) Meeting, Ottawa; August 17-19, 2001.
  • Struthers C, Davies RA, Glasgow I, Hendry P, Jackson MP, Lavallee G, Masters R, Mussivand, Zitouni L. First out of hospital experience of patient supported on Novacor left ventricular system: A multidisciplinary team approach. 6th Symposium World Artificial-Organ, Immunology and Transplantation Society (WAITS) Meeting, Ottawa; August 17-19, 2001.
  • Eisen H, Dorent R, Mancini D, et al for the RADB253 study group. R A Davies, local investigator, Safety and efficacy of everolimus (RAD) as part of triple immunosuppressive regimen in de novo cardiac transplant recipients: six month analysis; Washington; ISHLT April 2002.
  • Mussivand T, Harasaki H, Litwak K, Slaughter M, Gray L, Dowling R, Mueller R, Masters R, Hendry P, Beck-da-Silva L, Davies RA, Haddad H, Mesena T, Keon W. In vivo evaluation of the biocompatibility of a totally implantible VAD (HeartSaver VAD). 48th ASAIO Conference, New York, Ny, USA; June 13-15, 2002.
  • Davies RA, Haddad H, Bourke M, Runstedler B, Dafoe D, Bennet R, Struthers C, Hendry P, Masters R, Mesana T, Mussivand T, Keon W. Assessment of Reversibility of Refractory Pulmonary Hypertension Before Heart Transplantation with Nitric Oxide. Canadian Cardiovascular Congress, Edmonton, Alberta; October 2002. Can J Cardiol; 2002.
  • Davies RA, Haddad H, Badnovic K, Hendry P, Masters R, Struthers C, Veinot J, Smith S, Mussivand T, Mesana T, Keon W. Eighteen Year Experience with Heart Transplantation at the Ottawa Heart Institute: Comparison with Benchmark Canadian and International Results. Canadian Cardiovascular Society, Edmonton, Alberta October 2002 (Poster). Can J Cardiol; 2002.
  • Davies RA, Donati S, Marquis JF. Graphical Entry, Display and Report Generation of Coronary Angiography Data Using a Computerized Coronary Tree Diagram, CMBES Conference Proceedings, Ottawa; November 2002.
  • Eisen E, Dorent R, Mancini D, Valantine H, Vigano M, Starling R, Lind J, Bernhardt P, Abeywickrama K for the RADB253 Study Group (Davies RA. Local Investigator). Safety and Efficacy of Everolimus (RAD) as Part of a Triple Immunosuppressive Regimen in De Novo Cardiac Transplant Recipients: Six-Month Analysis; 2002.
  • P Hendry, R Masters, R A Davies, H Haddad, C Struthers, G Lavalle, I Glasgow, T Mesana, T Mussivand, W Keon. A Sixteen Year Experience with Mechanical Circulatory Support at the Ottawa Heart Institute; 2002.
  • Mussivand T, Hendry PJ, Masters RG, Haddad H, Davies RA, Mesana T. Mechanical Circulatory Support as a Bridge to Transplantation: A Life Saving Therapy that Leads to Improved Outcomes. Annual Scientific Meeting Canadian Society of Transplantation; Lake Louise, Alberta (Submitted); March 20-22, 2003.
  • Davies RA, Haddad H, Badnovic K, Hendry P, Masters R, Struthers C, Veinot J, Smith S, Mussivand T, Mesana T, Keon W. Heart Transplantation At The Ottawa Heart Institute: Comparison With Canadian And International Results. Accepted (poster), Canadian Society of Transplantation, Chateau Lake Louise; Transplant Proceedings in press; March 2003.
  • White, M on behalf of the Canadian Heart Transplant Group, Montreal (member). Prograf decreases plasma cholesterol in heart transplantation recipients with treated but persisting mild dyslipidemia: The Canadian multicenter randomized trial of Prograf versus Neoral. Canadian Society of Transplantation Annual Scientific Meeting. Lake Louise, Alberta; March 2003.
  • Ross H, Carrier R, Masters R, Haddad H, Cardella C, Delgado D, White M, Davies RA, Howlett J, Hirsch G, Kells C, O’Neill BJ, O’Grady C, Normandin D, Vezina J, Giddens K, Bernhardt P, Richard C, Hauck W. Everolimus (CerticanTM, RAD) reduces cardiac allograft vasculopathy. The heart intravascular ultrasound study. Canadian Society of Transplantation, Lake Louise, Alberta; March 2003.
  • Ukkonen H, de Kemp, Davies RA, Dafoe W, Burwash, Haddad H, Mostert K, Aung M, Tuddy T and Beanlands R, The Relationship Between Minute Ventilation and the Rate of CO2.
  • Elimination Reflects the Right Ventricular Oxidative Metabolism in Heart Failure. Submitted to American Heart Association Meeting; November 2003.
  • Yoshinga K, Chow B, deKemp R, Williams K, Garrard L, Aung M, Mosters K, Gauthier D, Davies RA, Ruddy T, Beanlands R, University of Ottawa Heart Institute, Ottawa, ON, Canada. Prognostic Value of Rubidium-82 Perfusion Positron Emission Tomography: Preliminary Results from the consecutive 153 Patients. Submitted to the American College of Cardiology meeting; September 2003.
  • Ukkonen H, deKemp R, Davies RA, Dafoe W, Burwash I, Haddad H, Mostert K, Aung M, Ruddy T, and Beanlands R. The Relationship between Minute Ventilation and the Rate of CO2 Elimination Reflects the Right Ventricular Oxidative Metabolism in Heart Failure. Submitted to the American College of Cardiology meeting; September 2003.
  • Tesson F, Bilinska, Veinot, Fidzianska, Ruzyllo, McBride, Davies RA, Chan K, Tang A. Contrasted molecular mechanism associated with lamin A/C mutations in end- stage dilated cardiomyopathy patients. Accepted American Heart Association; November 2003.
  • Tesson F, Bilinski ZT, Veinot JP, Fidzianska A, McKeown P, Ruzyllo W, McBride H, Davies RA, Chan KL, Tang A, Bolongo PP. Contrasted molecular mechanisms associates with lamin A/C mutations in end-stage dilated cardiomyopathy patients. American Heart Association Scientific Sessions, Orlando, Florida; November 9-12. 2003.
  • Hauck W, Gianetti N, Ross H, Carier M, Davies RA, Perrone S, Hauck W, Otero A, Radeva JI, Reed SD, Kalo Z, Kauf TL, Schulman KA. Economic evaluation of everolimus as part of triple immunosuppressive therapy in a phase 3 de novo heart transplant trial. The Canadian Journal of Cardiology. Canadian Cardiovascular Congress; Vol 19, Abstract 55; October 2003.
  • Hauck W, Haddad H, Davies RA, Masters R, Ross H, Delgado D, Perrone S, Carrier M, White M, Howlett J, Hirsch G, Otero, A, Hauck W. Determination of optimal everolimus concentrations in de novo heart transplantation: Use of therapeutic drug monitoring simulations. The Canadian Journal of Cardiology. Canadian Cardiovascular Congress; Vol 19, Abstract 56; October 2003.
  • Hauck, W, Perrone S, White M, Carrier M, Delgado D, Ross H, Haddad H, Masters R, Davies RA, Howlett J, Hirsch G, Otero A, Hauck W. Everolimus is associated with a reduced incidence of CMV infection in heart transplantation. The Canadian Journal of Cardiology. Canadian Cardiovascular Congress; Vol 19, Abstract 57; October 2003.
  • Hauck W, Delgado D, Perrone S, Ross H, Carrier M, White M, Haddad H, Masters R, Davies RA, Howlett J, Hirsch G, Otero A. Everolimus reduces cardiac allograft vasculopathy in de novo heart transplant recipients: 24 month follow up. The Canadian Journal of Cardiology. Canadian Cardiovascular Congress; Vol. 19 Abstract 153; October 2003.
  • Haddad H, Beck-da-Silva L, Fraser M, Williams K, Struthers C, Davies RA. Effect of orlistat in obese patients with heart failure: A pilot study. The Canadian Journal of Cardiology. Canadian Cardiovascular Congress; Vol 19, Abstract 737; October 2003.
  • Ukkonen H, Ruddy TD, Davies RA, Garrard L, Firnau G, Hendry P, deKemp R, Aung M, Beanlands RS. The right to left ventricular glucose uptake ratio predicts left ventricular function recovery after revascularization in heart failure. The Canadian Journal of Cardiology. Canadian Cardiovascular Congress; Vol 19, Abstract 633; October 2003.
  • Beck-da-Silva L, de Bold A, Fraser M, Williams K, Struthers C, Haddad H, Davies RA. Brain Natriuretic peptide levels predict successful cardioversion and rhythm maintenance in patients with atrial fibrillation. The Canadian Journal of Cardiology; Canadian Cardiovascular Congress; Vol 19, Abstract 758; October 2003.
  • Dalipaj MM, Madison S, Davies RA, Beanlands RS, Ruddy TD. The effects of gender and stress on transient ischemic dilation ratios in low probability normals. The Canadian Journal of Cardiology. Canadian Cardioascular Congress; Vol 19, Abstract 860; October 2003.
  • Haddad M. Masters RG, Hendry PJ, Mesana T, Davies RA, Mussivand T, Keon WJ. Improved outcomes with the total artificial heart. The Canadian Journal of Cardiology. Canadian Cardiovascular Congress; Vol 19, Abstract 867; October 2003.
  • Haddad H, Davies RA, Masters R, Ross H, Delgade D, Carrier M, White M, Howlett, J, Hirsch G. Determination of optimal everolimus concentrations in de novo heart transplantation: Use of therapeutic drug monitoring simulations. Canadian Society of Transplantation Meeting, Mt. Tremblant, Quebec; February 2004.
  • Ukkonen H, deKemp R, Davies RA, Dafoe W, Burwash I, Haddad H, Mostert K, Aung M, Ruddy T, Beanlands R. The relationship between minute ventilation and the rate of CO2 elimination reflects the right ventricular oxidative metabolism in heart failure. American College of Cardiology, New Orleans; March 8, 2004.
  • Davies R, Beanlands R, Ruddy T, Davies RA, Faber T, Santata C, deKemp R. Standards for evaluation of myocardial viability with FDG-positron emission tomography: A comparison of quantitative methods. American College of Cardiology, New Orleans; March 9, 2004.
  • Yoshinaga K, Chow B, deKemp R, Williams K, Garrard L, Aung M. Mostert K, Gauthier D, Davies RA, Ruddy TD, Beanlands R. Prognostic value of rubidium-82 perfusion positron emission tomography: Preliminary results from the consevutive 293 patients. American College of Cardiology, New Orleans; March 8, 2004; JACC 43: 338A; 2004.
  • White M, Haddad H, Genest J, LeBlanc MH, Racine N, Pflugfelder P, Giannetti N, Davies RA, Azevedo E, Isaac D, Burton J, Ferguson R, Ross H. Subclinical inflammation and prothrombotic state in stable long-term heart transplantation recipients with treated but persistent mild dyslipidemia. American Transplant Congress; Boston, MA; May 14-19, 2004.
  • Yoshinaga K, Ukkonen H, Burwash I, deKemp R, Dafoe W, Davies RA, Haddad H, Ruddy TD, DaSilva JN, Beanlands R. Myocardial efficiency reserve predicts the change of exercise capacity over time in patients with heart failure. Scientific Session; 2004; New Orleans Nov 7-10 2004.
  • Mielniczuk L, Davies RF, Beck daSilva L, deBold A, Davies RA, Fraser M, struthers C, Haddad H. B-Type Netruiretic Peptide (BNP) in the clinical titration of beta blocker dosage in heart failure patients. Submitted to Canadian Cardiovascular Society; 2004.
  • Lortie M, Renaud K, Mostert L, Garrard M, Aung M, Gardner K, DaSilva J, Davies RA Chow B, Ruddy T, Beanlands R, deKemp R. Myocardial blood flow quantification with Rb-82 and N-13-ammonia PET in healthy volunteers. Canadian Cardiovascular Society, Calgary, AB; October 2004.
  • Yoshinaga K, Chow B, deKemp R, Williams K, Garrard L, Szeto A, Aung M, DaSilva J, Davies RA, Ruddy T, Beanlands R. Prognostic value of rubidium-82 perfusion positron emission tomography: preliminry results from the consecutive 293 patients. Canadian Cardiovascular Society; Calgary, AB; October 2004.
  • Davies RA, Williams W, Baker A, Donaldson J, Veinot J, Haddad H, Struthers C, Masters R, Hendry P, Mesana T. Comparison of trough and peak cyclosporine levels after heart transplantation. Canadian Cardiovascular Society; Calgary, AB; October 2004.
  • Elabbassi W, Masters R, Hendry P, Davies RA, Mesana T, Pugliese C, Struthers C, Haddad H. Listing status at the time of transplantation: Impact on short and long term survival. National Society of Transplantation. Lake Louise, AB; March 2005.
  • Elabbassi W, Davies RA, Masters R, Hendry P, Mesana T, Naas, A, Struthers C, Pugliese C, Haddad H. Patients who ceased to breathe while on the transplant waiting list: Experience from the Ottawa Heart Institute; National Society of Transplantation. Lake Louise, AB; March 2005.
  • Thompson K, Saab G, Chow B, deKemp RA, Ananthasubramaniam K, Garrard L, Gauthier D, Dalapaj M, DaSilva J, Davies RA, Ruddy TD Beanlands RS. Reduced septal glucose metabolism in patients with left bundle branch block. Submitted to CCC Congress; Montreal, QC; Oct. 2005.
  • Yoshinaga K, Ukkonen H, Burwash I, deKemp R, Dafoe W, Davies RA, Haddad H, Ruddy TD, DaSilva JN, Beanlands R. Myocardial efficiency reserve predicts the deterioration in exercise capacity over time in patients with heart failure. Poster presentation. Volume 45, No. 3, supplement A; ACC, Orlando, Florida, USA; 2005.
  • Sylvius N, Bolongo PM, Bilinska ZT, Veinot JP, Davies RA, McBride H, Tuana BS, Tesson F. Functional significances of lamin A/C gene mutations in heart failure. Canadian Cardiovascular Congress. Montreal, QC; October 22-26, 2005.
  • Davies RA, Badovinac K, Trpeski L, Hendry P, Masters R, Haddad H, Veinot J, Smith S, Struthers C, Pugliese C, Ruel M, Rubens F. Determinants of survival after heart transplantation. Canadian Cardiovascular Congress; Montreal, QC; October 22-26, 2005.
  • Davies RA, Trpeski L, Badovinac K, Wells G. Effect of socioeconomic status and distance on survival following heart transplantations. Canadian Cardiovascular Congress. Montreal, QC; October 22-26, 2005.
  • Thompson K, Saab G, Chow B, deKemp RA, Ananthasubramaniam K, Garrard L, DaSilva J, Davies RA, Gauthier D, Dalipaj M, Ruddy TD, Beanlands RS. Reduced septal glucose metabolism in patients with left bundle branch block. Canadian Cardiovascular Congress; Montreal QC; October 22-26, 2005.
  • Yoshinaga K, Chow BJW, deKemp R, Williams K, Garrard L, Lok-Tin Szeto A, Chen L, Davies RA, Ruddy T, Beanlands R. Prognostic value of rubidium-82 perfusion positron emission tomography in patients referred after spect imaging. Canadian Cardiovascular Congress; Montreal, QC; October 22-26, 2005.
  • Yoshinaga K, Ukkonen H, Burwash IG, deKemp R, Dafoe W, Davies RA, Haddad H, Williams K, Chen L, Ruddy TD, Dasilva JN, Beanlands R. Myocardial Efficiency reserve predicts the change of exercise capacity over time in patients with heart failure. Canadian Cardiovascular Congress; Montreal, QC; October 22-26, 2005.
  • Yoshinaga K, Chow BJW, deKemp R, Williams K, Garrard L, Lok-Tin Szeto A, Chen L, Davies RA, Ruddy T, Beanlands R. Prognostic value of rubudium-82 perfusion positron emission tomography in patients with obesity. American Heart Association. Dallas, Texas, USA; November 13-16, 2005.
  • Tesson F, Davies RA. Disruption of sumo pathway: A new mechanism for lamin a/c gene associated diseases. American Heart Association; Dallas, Texas, USA; November 13-16, 2005.
  • Yoshinaga K, Chow BJ, Williams K, Chen Lm deKemp R, Garrard L, Lok-Tin Szeto A, Davies RA, Ruddy T, Beanlands RS. Prognostic value of rubidium-82 perfusion positron emission tomography in patients with obesity. Accepted. American College of Cardiology; Georgia World Congress Centre; March 16, 2006.
  • Leenan F, Coletta E, Davies RA. Prevention of Renal Dysfunction and Hypertension by Amlodipine after Heart Transplantation. American Journal of Cardiology, 2007.
  • Horsley T, Gow RM, Wells G, Sampson M, Davies RA. Cardiac Wait Time Benchmarks and Policies – Canada and Comparable Jurisdictions; CCS October 2007.
  • Hayani O, Mielniczuk l, Fraser M, Cassan D, Davies RA, Rouphael, Alghamdi A, Haddad H. The incidence and prognosis of hyperuricemia in heart failure. Can J Cardiol 2008, 24 175E
  • Mielniczuk L, Chandy G, Stewart DJ, Bencze S, Haddad H, Pugliese C, Bennett, Sherrard, Davies RA. Impact of multidisclinary pulmonary hypertension clinic on diagnosis and management. Can J Cardiol 2008, 24: 178E
  • Beanlands Rs, Nichol G, deKemp R. Garrard L, Williams K, Guo A, Ruddy TD, Chow B, Davies RA, Duchesne L, Haddad H, Higginson L, Hendry P, Masters RG, Mesana T, daSilva JN. FDG PET viability imaging to guide therapy improves clinical outcomes in patients with severe LV dysfunction compared with standard care at an experienced site with FDG readily available. A substudy of the PARR2 trail. Can J Cardiolo 2008, 24: 237E
  • Mielniczuk L, Hayani O, Fraser M, Davies RA, Rouphael R, Haddad H. The interaction between glomerular filtration rate and microalbuminuria in chronic heart failure. Can JCardiol 2008, 24: 286E
  • A Labib S., Boudreau E., Gupta P., Hamza A., Bolongo P., Bilinska Z.T., Davies R., Steart A.F.R., Burgon P., and Tesson F.; Effect of DCM-causing lamin A/C mutations on the interaction with SUMO E2 conjugating enzyme UBC9; 1st Annual Canadian Human Genetics Conference April 9-12, 2008, St-Sauveur, QC.
  • Ruddy TD, Mohammad, MH, Chow BJ, Dalipaj MM, de Kempt RA, Ali I, Wells RG, Davies RA, Beanlands RS; Extent of Dipyridamole Induced Hypoperfusion with 99mTc Tetrofosmin and Sestamibi SPECT Imaging compared to 82Rb PET Imaging. Soc Nucl Med

BOOK CHAPTERS

  • Zaret BL, Davies RA, Thakur ML, Berger HJ, Wachers FJ, and Gottschalk A. Imaging the inflammatory response to acute myocardial infarction in Indium-111 Labelled Neutrophils, Platelets and Lymphocytes, ed Thakur ML and Gottschalk A, Trivirum Publishing Co., 151 - 157, 1980.
  • Higginson LAJ, Williams WL, Baird MG, Davies RA, Beanlands DS Prediction of outcome following acute myocardial infarction using non-invasive techniques, in Clinical Essays on the Heart, ed by Hurst JW Publisher, Volume 1, 59 - 84, 1983.
  • Willis JE, Davies RA, Akyurekli Y, Ascroft FV, Beanlands DS. Non-invasive comparison of ventricular function with ventricular versus atrial ventricular sequential pacing in complete heart block, in Cardiac Pacing: Electrophysiology. Tachyarrhythmias, ed FP Gomez, (Dr. Willis, Research Fellow; senior author, Dr. RA Davies). Imprenta Fareso, 588-593, 1985.
  • Davies RA, Zaret BL, First-pass radionuclide ventriculography in Clinical Cardiovascular Imaging, ed. Douglas Miller, McGraw-Hill Company, 87 - 102, 1988.
  • Davies RA, Ruddy TD, Ballinger JR, Spencer P and Habibi H. Exercise myocardial imaging: Comparison between iodine-123-phenylpentadecanoic acid and thallium-201 in Radioactive Isotopes in Clinical Medicine and Research, ed R Hofer and H Bergmann, Schattauer Press, 610 - 615, 1988.
  • Davies RA, Baird MG, Ruddy TD, Chan K, Ascah KJ: Noninvasive assessment of coronary artery disease, in Advances in the Diagnosis and Treatment of Coronary Artery Disease. ed. Keon WJ, Beanlands DS, Farrell EM, Blackwell Scientific Publications, Boston, 37-90, 1990.
  • Mai F, Davies RA. The emotional state of the individual after heart transplant. Book chapter, Conference Proceedings, Feb. 1996.

COPYRIGHT

  • Davies RA, Haider M, Heart Transplant Database Manager © 1989: original prototype of Heart Transplant Database written in ZIM, programming assistance from Mr. M. Haider.
  • Davies RA, Patient Data Manager © 1994: prototype written in ZIM 5.0 for Windows, programming assistance from Mr. D. Bersinic of Bradley Systems and Mr. B. Payeur of Boreal Informatics, and others.
  • Davies RA, Patient Data Manager © 1990-1996: Heart Transplant Database in clinical use, continuously updated, rewritten in ZIM language version 4.2 during 1996-7, programming assistance from Mr. D. Bersinic of Bradley Systems and Mr. B. Payeur of Boreal Informatics, and others.
  • Davies RA, Patient Data Manager © 1996-7: prototypes written with PowerBuilder versions 4.0 and 5.0, programming assistance from Mr. R. Menard and Mr. K. Green from AJJA Information Technologies Inc.
  • Davies RA, Patient Database Management Software © 1998; written with PowerBuilder application development software for Windows 95 and Microsoft SQL server database software for Windows NT, programming assistance from Mr. S. Donati of Digigraph Inc. and Mr. R. Menard of Chasse Integrated Systems Inc.
  • Davies RA, Patient Database Management Software © 2002; written with PowerBuilder application development software for Windows 2000 and Microsoft SQL server database software for Windows NT, programming assistance from Mr. S. Donati of Fortisoft Inc.

Share This